hg_242487.1

Basic information about the TSS

---

TSS ID: hg_242487.1 Species: human Chr: chr7		Start: 76302578 End: 76302590 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: FJ224323 U90906 Distance: 16 GeneID: 3315 HGNC/MGI_ID: HGNC:5246 UniProt_ID: V9HW43

Gene_name: heat shock protein family B (small) member 1 Gene_symbol: HSPB1 Gene_synonyms: CMT2F HSP27 HSP28 Hs.76067 Hsp25 Gene_source: HGNC:5246

TATA-Box annotation

---

Distance to TSS:	27
Nearest PromoterID:	NM_181775
Entrez ID:	91584
Nearest Unigene:	Hs.511454
Nearest Refseq:	NM_020911
Nearest Ensembl:	ENSG00000221866
Gene Name:	heat shock protein family B (small) member 1
Gene Alias:	FAYV2820|PLEXA4|PLXNA4A|PLXNA4B|PRO34003
Gene Description:	plexin A4
Gene Type:	protein-coding
CpG%:	0.01
GC%:	0.502488
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HSPB1 p2@HSPB1 p3@HSPB1 p4@HSPB1 p5@HSPB1 p6@HSPB1 p7@HSPB1 p8@HSPB1 p9@HSPB1
Sample		p1@HSPB1	p2@HSPB1	p3@HSPB1	p4@HSPB1	p5@HSPB1	p6@HSPB1	p7@HSPB1	p8@HSPB1	p9@HSPB1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	158.76	33.12	27.66	11.30	1.56	2.53	0.58	1.56	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	156.19	42.89	30.35	10.12	0.40	2.02	1.42	1.21	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	166.28	35.88	28.74	11.77	1.16	2.89	0.58	2.12	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	148.66	39.30	27.03	10.19	0.83	1.66	0.21	2.91	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	162.20	38.47	27.45	11.25	1.57	2.47	0.67	1.57	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	172.30	37.99	29.85	11.05	1.16	4.65	0.78	2.52	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	162.11	54.04	51.86	16.78	3.92	4.14	0.65	1.09	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	148.24	40.69	50.38	17.68	3.63	5.81	1.70	1.45	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	150.46	46.16	46.38	15.17	2.14	4.27	1.28	1.07	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	156.50	15.65	33.04	4.64	1.16	1.16	0.58	2.32	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	139.87	23.45	31.53	3.23	1.21	3.64	0.00	1.62	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	141.07	21.55	29.68	4.88	1.63	2.44	0.81	2.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	1089.66	124.60	46.10	1.13	1.61	1.45	2.90	19.18	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	1017.27	116.97	36.69	2.41	0.60	0.90	3.31	15.04	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	944.30	114.39	38.20	1.98	0.44	1.10	3.07	13.61	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	1213.19	110.66	37.98	1.76	1.26	1.51	2.26	17.10	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1145.11	107.46	32.54	2.40	0.66	1.97	2.18	13.98	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	1161.26	133.29	34.59	1.69	0.84	2.53	1.27	17.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	1184.67	115.16	35.19	2.67	0.53	1.07	1.07	14.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	923.26	135.55	43.93	2.86	1.05	1.05	2.41	17.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	1048.63	120.42	37.56	1.07	0.53	1.34	2.27	14.43	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	1069.06	127.74	39.88	1.73	0.52	1.04	2.42	11.74	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	1089.51	107.15	37.48	1.94	0.52	0.90	1.42	10.08	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1141.51	107.74	37.37	1.70	0.97	1.46	2.18	11.41	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	1187.01	117.90	31.73	2.06	0.52	0.52	1.81	17.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	1185.97	141.48	37.03	1.90	0.32	0.63	0.95	16.78	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	1328.04	148.90	35.71	3.30	0.00	1.65	1.10	20.33	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	1405.32	128.01	42.20	2.59	0.24	1.89	2.83	18.62	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	1212.07	154.58	38.44	2.10	0.65	1.45	2.75	16.48	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	1336.07	113.10	37.82	1.99	1.09	1.09	3.26	15.02	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	1492.83	126.65	38.31	2.72	0.21	1.47	1.88	20.10	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	1406.36	118.01	36.73	2.34	0.59	0.59	2.15	22.66	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	1494.93	160.38	42.21	2.11	0.63	1.90	2.11	18.36	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	1541.53	157.02	39.42	1.65	0.33	1.48	1.98	29.52	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	1464.50	112.19	40.39	2.62	0.37	0.93	2.80	28.05	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	1455.00	96.39	38.90	1.92	0.57	0.96	2.49	18.40	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	1458.46	114.04	34.95	2.86	0.61	1.23	3.07	22.89	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	1480.12	112.43	39.09	2.01	0.60	1.21	1.41	17.53	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	1446.67	112.09	32.14	1.89	0.54	1.89	1.08	20.80	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	1333.54	102.99	33.61	1.68	0.72	0.48	1.44	11.76	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	1508.72	100.69	33.64	3.29	0.47	0.94	2.35	15.53	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1591.31	107.89	36.01	3.07	0.88	1.61	1.90	23.42	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	1416.78	84.99	35.01	2.32	1.27	0.63	2.74	22.14	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	1533.41	115.74	33.57	2.97	0.87	0.70	2.80	21.33	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	1342.37	89.95	35.94	2.21	1.20	2.01	1.81	19.27	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	1495.45	107.48	35.36	2.09	0.93	1.63	3.95	29.31	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	1626.32	95.24	31.67	1.92	0.72	0.96	2.64	21.59	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	1458.66	112.07	39.64	2.68	1.19	1.19	2.38	24.44	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	1823.31	87.37	39.26	1.68	0.96	0.72	2.39	28.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1573.50	119.70	38.62	1.62	0.61	0.81	1.01	28.91	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	1589.42	102.68	34.23	2.25	0.82	0.82	0.61	23.16	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	1891.52	89.62	30.47	2.00	0.22	1.78	2.67	24.91	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1693.05	55.97	13.99	0.00	0.00	0.00	0.00	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	1874.72	71.68	26.61	1.77	0.71	1.42	1.06	8.52	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	1726.84	62.30	26.84	0.66	0.33	0.66	0.33	10.27	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1338.94	125.84	43.62	1.68	2.52	1.68	1.68	31.04	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1366.70	84.04	35.36	3.67	0.46	1.38	1.38	26.64	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	1983.54	51.53	22.36	0.32	0.65	0.32	0.97	14.91	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1983.86	34.69	18.95	1.93	0.64	0.64	2.57	14.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1627.29	57.84	27.98	2.83	1.26	1.57	0.94	37.72	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	2030.56	37.37	15.51	0.00	1.41	0.00	1.41	8.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	2008.18	37.01	14.58	0.56	1.12	0.56	1.12	10.09	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	1683.05	41.40	28.66	3.18	1.59	3.18	1.59	34.23	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	1459.64	45.19	19.37	1.36	0.68	0.68	0.68	22.76	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	1850.42	25.02	10.07	0.97	0.00	0.65	0.97	11.70	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	1978.66	18.81	11.00	0.35	0.35	0.00	0.35	11.36	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1567.90	32.33	0.00	0.00	0.00	0.00	0.00	0.00	64.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1721.65	31.59	7.90	0.00	0.00	0.00	0.00	0.00	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	2143.12	6.83	6.34	1.46	1.95	0.49	0.00	10.24	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	1948.28	14.88	7.93	0.50	0.00	0.00	0.00	9.42	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	1996.08	10.79	5.63	0.47	0.47	1.41	0.00	10.79	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	1719.20	5.30	15.57	1.99	0.66	0.99	0.00	10.60	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	1852.03	6.81	10.21	1.24	0.93	0.31	0.62	8.35	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	1763.84	7.95	6.42	0.92	0.31	0.00	0.00	11.31	0.92
Adipocyte - breast, donor1	11376-118A8	9685.65	20.59	14.89	2.53	0.95	1.43	1.11	55.91	3.64
Adipocyte - breast, donor2	11327-117E4	4790.34	21.82	16.68	0.96	1.28	1.60	1.60	27.91	0.48
Adipocyte - omental, donor1	11473-119C6	10194.87	18.45	17.18	4.45	1.40	2.16	0.25	48.86	3.82
Adipocyte - omental, donor2	11474-119C7	6403.02	10.46	10.46	1.49	0.00	2.24	1.49	48.59	2.99
Adipocyte - omental, donor3	11475-119C8	5976.30	21.43	17.75	1.67	0.33	0.67	0.67	93.11	2.01
Adipocyte - perirenal, donor1	11476-119C9	4417.44	16.59	22.33	0.64	0.64	0.00	1.28	24.88	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	4429.91	24.19	20.89	3.30	1.10	0.00	0.00	52.78	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	957.90	37.03	18.52	7.23	1.35	1.35	0.90	7.23	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	537.84	47.09	18.94	4.34	0.70	0.87	0.52	6.26	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	472.70	67.28	27.77	1.96	0.98	0.59	1.37	6.65	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	371.40	38.09	17.76	1.80	0.26	0.26	0.51	2.83	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	870.89	36.80	30.66	4.46	1.12	0.28	1.12	4.46	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	489.65	68.77	31.15	1.18	1.18	1.18	0.59	2.94	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	750.36	58.23	31.85	3.22	0.40	0.64	1.85	7.64	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	574.50	52.61	22.59	2.58	0.00	0.65	1.29	4.52	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	436.68	43.72	27.19	1.60	0.53	0.53	1.07	9.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	751.75	37.28	25.60	3.90	2.23	0.00	0.00	2.23	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	1108.77	31.19	34.10	1.66	0.42	0.83	2.50	14.14	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	686.69	38.68	24.61	1.76	0.75	0.25	0.25	4.27	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	810.91	20.62	20.29	2.29	0.33	1.31	0.33	7.53	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	850.69	18.27	12.79	1.22	0.00	0.61	0.61	5.78	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	3615.96	35.14	60.11	7.51	2.43	1.55	2.43	3.98	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	1396.32	25.82	55.94	6.81	1.08	0.36	2.15	8.96	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	1256.72	50.32	38.34	4.79	0.00	0.00	1.20	3.59	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	728.26	14.03	41.38	5.40	1.80	1.98	0.72	0.36	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	820.01	15.06	41.84	5.02	0.00	1.67	0.00	5.02	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	1634.95	13.76	25.27	3.90	1.64	2.88	1.23	3.90	0.21
Anulus Pulposus Cell, donor1	11248-116E6	870.90	85.93	40.96	4.58	1.26	2.29	0.34	2.98	0.34
Anulus Pulposus Cell, donor2	11463-119B5	425.89	57.31	31.10	2.94	0.24	0.73	1.71	3.18	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	1703.73	26.51	18.42	6.29	0.45	2.25	0.45	2.70	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	2119.91	33.86	28.65	2.60	1.74	0.43	2.60	3.91	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	1583.78	19.26	21.40	0.00	0.00	0.00	0.00	6.42	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	1713.12	25.11	25.11	3.89	0.30	0.90	1.20	4.48	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1817.30	24.03	30.35	6.32	1.26	0.00	0.00	5.06	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1419.81	19.14	17.16	1.98	1.32	0.00	0.00	4.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	1631.58	24.69	17.87	4.22	0.65	1.30	0.97	3.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	1902.93	26.21	23.79	2.91	0.49	0.49	0.97	2.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1668.21	21.38	14.85	2.97	1.19	0.59	0.00	3.56	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	1667.00	24.86	21.09	2.64	0.75	0.75	1.13	6.03	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	1827.97	36.28	25.40	4.35	0.73	0.00	0.00	2.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1616.12	22.57	17.55	2.51	0.00	0.00	0.00	3.76	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	1876.18	23.23	27.18	3.46	0.99	1.15	1.48	0.99	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1940.75	16.38	16.38	1.36	0.00	1.36	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	1208.14	14.48	19.00	2.26	0.60	0.75	0.75	2.41	1.36
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1696.30	19.29	12.86	3.21	0.00	1.07	0.54	3.21	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	1547.57	19.27	20.78	4.35	0.76	0.76	0.94	2.83	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	1803.38	21.38	17.11	2.14	0.27	0.27	0.80	4.54	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1770.45	19.51	16.58	2.93	0.00	0.00	0.98	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	1564.39	21.40	23.39	3.65	0.50	0.83	1.00	2.65	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1681.01	18.01	20.41	0.00	0.00	1.20	0.00	7.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	2623.25	35.40	10.62	0.00	0.00	0.00	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	1644.80	18.01	22.99	3.26	0.51	1.03	1.20	2.40	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	2034.56	12.58	12.58	4.19	0.00	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	1825.20	24.27	17.96	1.94	1.46	1.46	0.97	3.88	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	1879.80	23.53	35.29	5.69	0.76	1.52	0.38	4.93	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1668.05	13.33	19.38	7.27	1.21	0.00	1.21	3.63	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	1851.47	21.66	15.96	1.14	1.14	1.14	0.57	3.42	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	1765.99	22.02	19.24	2.35	0.21	0.64	0.86	3.42	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	1698.49	21.68	17.03	2.06	0.26	1.29	0.52	4.39	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	2062.16	31.44	23.93	5.16	0.94	0.00	0.47	2.82	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	1809.68	21.54	22.19	2.89	0.96	0.32	1.93	3.86	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	1668.05	19.26	17.84	4.28	0.71	0.00	1.43	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1872.43	25.74	19.30	2.92	0.58	0.58	0.00	2.34	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	1650.18	17.76	22.28	1.51	0.30	0.30	0.60	3.91	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	1623.98	17.82	23.76	3.56	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	2037.29	32.55	27.97	5.59	1.02	0.51	1.02	4.07	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	1660.06	28.02	25.72	3.57	0.76	1.02	0.76	3.06	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1523.61	19.06	19.06	1.91	0.00	0.00	0.64	2.54	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	1936.72	26.76	28.48	3.02	0.43	0.86	0.86	3.88	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	1527.95	22.44	19.69	2.54	0.21	0.42	0.21	3.18	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	1656.66	23.49	14.79	2.61	0.00	0.58	0.58	2.61	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	1998.12	20.78	21.73	4.72	2.83	1.89	3.78	1.89	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	1603.70	25.09	23.39	3.73	0.34	0.85	0.85	2.71	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	1873.94	18.53	16.21	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2484.38	25.35	27.46	0.00	0.00	0.00	2.11	4.23	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	1565.64	19.94	23.16	1.72	0.21	1.07	1.29	4.07	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	1863.35	19.25	19.25	3.61	0.00	1.20	1.20	3.01	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	1666.44	26.97	16.77	3.64	0.00	0.00	1.46	3.64	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	1665.26	19.77	25.29	2.99	0.92	1.61	1.38	3.45	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	1703.60	22.95	20.40	2.55	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1435.39	11.19	20.59	1.78	0.51	0.25	0.76	2.03	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	1759.48	18.99	27.46	3.92	1.24	0.41	1.65	3.30	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	1608.03	21.11	16.52	2.75	0.61	0.61	0.00	2.45	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1586.52	25.81	24.38	2.39	0.48	0.00	0.48	5.74	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	1506.06	16.63	16.41	2.44	0.44	0.67	0.44	3.55	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1528.85	13.73	13.73	1.53	0.00	1.53	0.00	6.10	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1515.44	25.48	18.83	1.66	0.00	1.11	0.00	4.43	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	1382.49	10.86	16.68	3.71	0.26	0.26	0.26	4.77	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1412.72	18.54	10.54	1.82	0.36	1.09	0.73	3.63	0.73
Astrocyte - cerebellum, donor1	11500-119F6	925.79	87.81	66.32	11.54	2.09	1.23	1.72	1.72	1.97
Astrocyte - cerebellum, donor2	11580-120F5	825.85	73.60	48.27	9.07	2.23	1.20	1.88	2.91	0.34
Astrocyte - cerebellum, donor3	11661-122F5	558.35	70.27	29.15	4.82	0.84	1.05	0.84	1.89	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	906.67	93.07	42.18	2.79	2.09	1.74	1.39	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	964.82	87.68	49.02	8.74	2.10	1.94	1.46	1.46	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	1285.46	61.75	32.96	4.92	0.89	1.64	1.34	2.54	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	334.42	7.57	43.24	38.08	6.77	5.73	0.23	1.38	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	358.81	9.77	38.46	37.84	7.02	6.14	0.25	0.75	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	338.66	8.53	41.42	34.25	6.94	6.15	0.11	0.80	0.11
Basophils, donor1	12241-129G9	12.29	2.88	23.01	5.23	1.05	1.57	0.00	0.00	0.00
Basophils, donor2	12242-129H1	10.10	1.08	18.40	9.74	1.80	2.16	0.00	0.36	0.00
Basophils, donor3	12243-129H2	28.81	2.50	13.23	3.97	1.47	1.18	0.00	0.44	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	11236.58	31.48	40.75	3.23	0.43	1.08	1.72	17.25	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	9924.13	58.98	71.32	5.49	2.29	0.91	3.20	47.09	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	6011.45	35.87	28.69	14.35	0.00	0.00	0.00	14.35	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	1775.00	8.79	23.22	1.26	1.26	1.26	0.63	10.67	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	1196.55	18.09	20.80	2.91	0.83	0.42	0.62	2.91	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	847.93	10.13	22.57	3.22	0.00	0.69	0.46	3.91	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	3466.64	30.05	36.71	3.24	2.16	2.34	1.98	7.92	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.52	50.39	146.44	41.84	34.11	16.49	1.55	0.21	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	109.04	312.42	151.57	24.30	16.63	8.95	0.64	1.60	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	320.60	196.50	206.84	31.03	0.00	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	24.80	1.69	19.72	6.20	1.69	1.69	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	3.71	2.04	15.96	4.45	1.30	1.48	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	3.51	1.76	20.42	3.95	1.98	0.88	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	288.99	16.98	22.93	4.81	1.13	0.28	0.28	7.08	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	397.65	14.03	15.16	6.07	1.14	0.76	0.38	6.82	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	284.36	12.82	22.68	4.27	1.31	0.66	0.00	5.92	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	5.20	1.73	8.67	0.00	0.43	0.43	0.00	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	9.96	2.11	9.05	0.00	0.00	0.60	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	47.62	0.95	10.42	0.95	0.24	0.71	0.24	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.19	1.00	6.36	0.50	0.50	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.56	1.66	8.56	0.28	0.55	0.28	0.00	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	41.65	1.98	6.94	0.25	0.50	0.25	0.00	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.49	0.39	6.66	0.78	0.00	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.96	1.60	9.97	0.18	0.36	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	58.76	0.87	14.58	0.65	0.44	0.44	0.00	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	10.30	0.70	7.26	0.47	1.17	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	32.21	2.11	13.20	1.06	3.70	1.06	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	38.83	0.00	9.98	0.00	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.35	1.34	6.84	0.15	0.15	0.00	0.00	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.97	0.80	8.98	0.20	0.40	0.20	0.00	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	69.33	1.04	9.58	0.62	0.42	0.00	0.00	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.03	1.14	4.80	0.46	0.46	0.23	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	16.97	1.13	7.92	0.90	0.00	0.45	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	64.16	0.44	4.80	0.00	0.00	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.38	2.15	5.65	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.12	2.79	15.70	0.70	0.87	0.17	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	37.03	0.84	9.68	0.00	0.84	0.00	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.67	1.65	4.96	0.18	0.37	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	12.33	1.41	5.64	0.00	0.35	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	39.49	1.32	5.26	0.44	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	12.38	1.22	6.10	0.17	0.35	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.01	1.86	11.52	0.00	0.00	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	33.84	0.65	10.78	1.08	0.00	0.43	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	123.67	1.64	5.32	0.41	0.00	0.41	0.00	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.68	0.93	7.88	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	31.55	2.09	7.42	0.00	0.23	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	27.68	5.01	40.11	3.49	4.58	1.96	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	13.86	4.62	37.88	4.62	4.39	0.92	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	20.15	4.33	34.66	3.03	1.73	0.87	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	2.34	2.34	22.89	2.49	2.80	1.25	0.00	0.31	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	1.05	2.79	19.39	1.22	0.52	0.52	0.00	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	3.12	1.11	20.51	3.79	0.89	0.67	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	69.92	2.30	60.99	7.91	9.95	4.08	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	31.18	3.07	33.81	4.61	4.17	1.54	0.00	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	33.06	1.47	46.32	3.37	5.90	2.32	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	117.87	8.13	58.94	28.45	6.10	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	95.59	4.07	44.07	26.44	13.56	3.39	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	106.67	2.07	42.46	23.82	6.21	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	66.10	3.73	35.18	22.39	6.40	3.20	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	77.73	2.68	39.13	24.12	8.04	2.14	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	91.25	3.51	28.78	19.65	7.02	2.11	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	91.77	3.14	40.00	42.36	10.20	2.35	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	155.56	2.64	47.46	40.87	13.18	3.95	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	95.34	3.29	36.16	23.01	4.11	1.64	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	109.54	1.45	29.74	13.06	4.35	5.80	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	32.31	3.03	28.27	22.72	2.52	4.54	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	54.95	12.53	53.34	68.69	23.84	31.92	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	44.74	13.58	47.54	41.95	20.77	31.56	1.60	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	72.29	101.41	85.34	16.06	3.01	2.01	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	58.43	53.37	56.74	7.30	6.18	1.69	1.69	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	75.90	196.52	109.72	28.18	11.65	7.14	2.25	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	100.57	230.67	156.71	32.24	13.75	11.50	2.03	1.80	0.23
CD4+ T Cells, donor1	11225-116C1	7.86	4.64	147.46	27.85	18.92	11.78	0.36	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	11.63	6.74	127.37	27.56	15.31	11.02	0.61	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	14.64	5.18	93.02	25.01	10.37	8.54	0.30	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.51	4.34	91.37	30.88	17.10	9.19	0.26	1.28	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.45	2.70	90.06	23.36	12.80	5.84	0.00	0.90	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.57	4.89	71.29	37.66	17.25	10.64	0.29	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	19.44	24.65	222.82	62.58	38.40	16.12	0.95	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	23.88	31.60	267.58	65.32	36.52	22.47	0.00	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	26.37	178.00	39.55	16.48	9.89	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	6.21	4.48	46.24	22.54	5.93	4.19	0.00	0.58	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	4.74	2.03	46.26	21.69	6.78	3.90	0.00	0.51	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	5.32	1.77	37.24	20.47	5.16	3.55	0.16	0.48	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	17.93	6.72	79.80	20.62	9.86	5.38	0.00	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.53	4.19	98.88	28.30	11.53	5.94	0.35	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	8.80	6.60	84.04	25.52	8.36	4.84	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3.79	5.90	100.35	36.68	14.34	9.28	1.26	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	7.69	5.82	69.81	27.01	11.01	7.06	0.42	1.04	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	6.01	6.35	76.52	27.40	8.69	4.34	0.33	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	3.26	19.04	213.47	53.30	27.19	10.33	0.54	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	20.90	271.73	48.77	24.12	14.47	0.54	2.14	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	19.73	191.88	43.04	26.90	10.76	1.79	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	2.23	2.97	62.86	27.07	6.49	5.75	0.00	0.74	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1.95	2.60	40.29	22.74	5.20	4.12	0.00	0.65	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	1.26	0.42	31.10	22.70	7.15	3.36	0.42	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.71	12.13	175.95	34.38	21.74	8.60	0.00	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	13.00	12.13	168.10	38.99	21.66	13.43	0.43	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	14.38	5.23	140.33	41.40	18.30	10.02	0.00	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	11.88	12.37	166.28	55.43	26.72	12.87	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	12.00	20.31	132.02	65.55	22.16	15.69	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	12.56	25.12	175.87	60.02	33.50	9.77	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	12.46	18.83	179.17	67.57	22.43	9.69	0.55	1.94	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	14.48	16.44	209.56	88.10	30.18	11.53	0.25	1.47	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	21.56	12.32	186.34	36.96	27.72	7.70	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	14.32	12.89	156.86	58.02	28.65	11.46	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	11.08	15.23	142.65	60.94	38.78	9.69	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	5.57	5.24	56.31	26.19	12.77	6.22	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	9.01	1.88	46.55	22.90	6.01	4.88	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	5.81	10.10	93.67	31.56	15.65	12.37	1.01	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	863.43	50.70	52.07	29.82	4.36	4.59	0.69	1.84	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	821.97	48.89	46.25	28.04	3.35	3.35	1.44	2.16	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	893.00	63.75	58.55	28.45	6.57	7.39	1.09	1.37	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	848.40	48.33	55.54	34.82	3.90	7.51	1.50	2.70	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	852.18	55.44	52.32	33.60	6.00	4.80	0.96	2.16	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	775.16	46.61	47.98	28.42	5.91	6.59	0.68	1.36	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	952.79	60.62	54.76	23.90	5.43	4.13	1.52	2.17	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1041.24	56.59	45.80	27.64	5.00	4.21	0.26	1.32	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1013.58	63.08	49.72	20.17	5.39	3.75	1.17	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	871.22	74.56	50.72	28.38	2.72	5.13	1.21	2.11	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	902.02	76.11	62.46	26.44	6.68	4.94	0.87	2.03	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	816.35	55.42	54.09	29.31	3.73	2.93	1.33	1.33	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	956.49	35.46	28.89	23.20	2.63	3.50	0.88	2.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	977.35	42.35	26.87	20.04	2.28	4.10	1.37	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	971.13	39.53	32.07	29.09	3.73	4.48	1.49	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	880.94	45.74	57.26	32.05	5.76	7.20	2.52	2.52	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	792.67	50.93	43.45	33.09	2.01	3.45	0.58	3.16	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	748.57	48.08	52.80	29.93	6.84	4.95	0.24	2.59	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1084.45	60.85	62.75	31.69	5.07	3.80	0.95	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	999.58	53.82	47.67	26.14	4.00	4.31	1.54	2.15	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	905.33	45.84	47.45	27.25	4.81	3.85	1.92	1.92	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	838.36	44.37	43.22	26.39	3.06	5.35	1.53	1.91	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	832.74	42.56	52.42	27.19	5.91	3.55	1.18	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	866.85	36.31	52.95	27.99	3.03	6.05	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	1123.34	18.47	41.75	22.48	1.61	3.21	0.00	4.01	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	1020.47	27.28	32.87	29.38	2.80	5.60	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	1169.04	22.04	42.07	26.05	5.01	2.00	3.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	2103.73	47.52	21.93	1.83	0.00	1.83	0.00	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	1175.93	74.11	33.10	0.99	0.49	0.00	0.99	5.93	0.49
Cardiac Myocyte, donor3	11686-122I3	1035.70	39.67	21.68	1.26	0.53	0.21	1.16	0.95	0.21
Chondrocyte - de diff, donor1	11261-116G1	1026.13	20.45	16.64	1.73	0.69	0.00	0.00	7.28	4.51
Chondrocyte - de diff, donor2	11338-117F6	842.60	22.03	17.06	1.78	1.07	0.00	0.36	2.84	0.00
Chondrocyte - de diff, donor3	11410-118E6	717.03	37.66	25.37	3.53	0.23	0.68	1.93	3.41	0.57
Chondrocyte - re diff, donor2	11339-117F7	757.39	16.11	24.17	2.69	0.90	0.00	0.90	4.48	0.00
Chondrocyte - re diff, donor3	11411-118E7	664.03	8.09	18.20	2.02	0.00	0.00	0.40	3.24	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	714.71	164.68	58.76	5.05	1.26	2.07	1.49	2.18	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	944.42	114.58	47.24	2.78	0.64	1.28	2.57	3.42	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	677.45	134.34	41.24	2.74	0.27	1.24	2.30	2.74	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	1162.21	18.98	18.98	8.62	1.56	1.10	0.37	4.59	0.18
Corneal Epithelial Cells, donor1	11526-119I5	5882.57	34.47	59.94	3.51	1.54	0.22	0.88	7.03	0.88
Corneal Epithelial Cells, donor2	11606-120I4	24402.66	29.58	44.37	3.41	1.14	1.14	0.00	53.47	2.28
Corneal Epithelial Cells, donor3	11687-122I4	5929.35	43.97	50.61	5.88	1.53	1.28	2.81	13.80	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	716.35	14.36	6.60	2.15	0.99	0.33	0.33	2.48	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	593.60	10.41	5.05	2.21	0.00	0.63	0.00	2.21	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	521.06	10.35	6.90	3.45	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	589.41	11.34	10.37	1.94	1.30	0.11	0.00	3.02	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	7.52	3.42	30.06	10.59	7.17	2.39	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.79	4.57	40.48	18.28	7.18	5.88	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	11.13	7.26	48.39	14.52	8.23	1.45	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	1770.59	81.05	53.20	4.50	1.00	1.17	2.33	2.84	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	1664.10	92.71	61.61	3.52	0.00	0.59	3.52	4.69	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3102.00	129.52	83.71	5.09	0.85	1.41	2.83	3.96	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	1596.33	100.26	53.47	4.33	0.79	0.00	1.97	3.54	0.39
Endothelial Cells - Artery, donor1	11264-116G4	1447.10	105.01	72.72	4.94	0.58	0.58	3.78	10.18	0.29
Endothelial Cells - Artery, donor2	11341-117F9	1587.42	131.52	53.64	4.00	0.94	1.65	3.53	11.76	0.00
Endothelial Cells - Artery, donor3	11413-118E9	1380.03	56.62	32.96	4.03	0.35	0.35	1.40	2.98	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	1385.55	46.10	28.59	0.66	0.00	0.44	1.33	2.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	1487.26	46.86	37.42	3.04	0.61	0.91	0.61	3.04	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	1934.70	42.57	37.49	1.97	0.00	0.56	2.26	3.66	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	2511.37	89.44	39.82	3.57	0.30	0.59	2.67	18.72	6.83
Endothelial Cells - Microvascular, donor2	11342-117G1	1501.08	71.33	43.22	1.04	0.52	0.00	1.56	4.17	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	2971.00	71.18	26.37	2.41	0.28	0.14	1.56	29.63	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	2276.28	124.04	76.42	3.60	1.20	0.80	2.00	8.80	6.80
Endothelial Cells - Thoracic, donor2	11343-117G2	1917.77	57.13	36.16	2.62	1.05	0.52	1.57	5.77	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	3171.14	171.21	95.67	2.48	0.75	1.24	2.86	15.66	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	2223.02	127.10	74.52	2.61	0.43	1.30	3.48	8.47	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	2846.06	137.88	95.26	2.32	0.24	0.98	5.37	9.40	0.49
Endothelial Cells - Vein, donor1	11267-116G7	1724.46	105.79	52.33	3.41	0.00	2.28	5.69	4.55	1.14
Endothelial Cells - Vein, donor2	11344-117G3	1895.73	101.98	50.29	2.79	1.40	1.40	2.10	4.19	0.00
Endothelial Cells - Vein, donor3	11416-118F3	1444.31	121.52	64.69	3.30	1.26	0.63	2.83	4.71	0.47
Eosinophils, donor1	12244-129H3	15.25	0.00	45.74	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	1.65	0.00	1.65	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6770.28	34.69	40.80	2.44	2.44	1.95	1.71	9.04	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	11122.64	22.88	22.88	0.00	4.16	0.00	2.08	49.92	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	4067.19	16.27	32.54	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	1362.50	2.05	6.57	0.41	0.41	0.00	0.82	5.34	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1409.12	24.31	33.94	2.52	0.99	1.53	1.86	24.20	3.28
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	1091.29	48.32	33.91	3.90	0.87	1.30	0.98	14.30	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	1505.93	38.08	26.92	3.76	1.09	1.33	0.73	14.19	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1147.31	7.78	7.78	0.68	0.27	0.27	0.27	3.28	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	1858.36	35.02	31.22	2.64	0.63	1.16	1.27	16.77	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	688.50	11.33	4.22	0.53	0.53	0.00	0.00	7.38	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	1181.97	38.20	32.56	5.32	1.66	1.00	1.00	17.61	0.00
Fibroblast - Cardiac, donor1	11268-116G8	1408.51	29.49	26.31	3.63	0.91	0.45	2.72	1.81	0.00
Fibroblast - Cardiac, donor2	11345-117G4	2605.07	15.16	16.67	3.79	0.00	0.00	0.00	3.03	3.03
Fibroblast - Cardiac, donor3	11417-118F4	1809.95	27.13	28.55	3.47	1.10	0.79	1.26	12.62	0.47
Fibroblast - Cardiac, donor4	11452-119A3	825.06	50.92	24.25	3.03	0.30	0.61	0.30	2.12	0.30
Fibroblast - Cardiac, donor5	11456-119A7	663.96	28.30	22.84	2.16	0.63	0.13	0.89	4.06	0.13
Fibroblast - Cardiac, donor6	11460-119B2	823.31	31.68	17.13	2.12	0.30	0.00	1.52	2.88	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	275.62	64.45	40.73	5.23	0.54	0.67	0.67	0.80	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	202.77	32.36	19.41	4.31	0.00	0.43	0.00	1.73	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	1354.93	87.89	39.55	4.39	1.46	0.00	1.46	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	524.01	121.09	98.48	9.46	1.85	1.85	1.85	0.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	871.94	118.55	17.64	2.88	0.34	1.02	0.85	4.07	1.53
Fibroblast - Dermal, donor1	11269-116G9	577.56	76.30	28.88	3.76	0.47	0.23	0.94	5.40	0.00
Fibroblast - Dermal, donor2	11346-117G5	779.21	63.20	46.70	4.72	2.83	0.47	2.36	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	594.40	81.72	21.16	1.81	0.60	1.09	1.69	7.37	0.60
Fibroblast - Dermal, donor4	11450-119A1	373.28	41.04	35.04	6.56	1.13	0.68	1.36	0.68	0.11
Fibroblast - Dermal, donor5	11454-119A5	381.70	50.24	35.41	5.76	1.22	0.70	1.40	1.22	0.52
Fibroblast - Dermal, donor6	11458-119A9	472.33	52.14	36.38	7.80	1.46	0.81	1.62	1.62	0.16
Fibroblast - Gingival, donor1	11237-116D4	389.81	73.30	46.44	4.16	1.87	0.62	1.46	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	1869.11	46.37	40.87	3.67	1.31	1.83	2.36	36.68	0.26
Fibroblast - Gingival, donor2	11318-117D4	331.04	66.02	43.75	9.62	1.71	1.32	1.71	1.19	0.13
Fibroblast - Gingival, donor3	11394-118C8	503.45	60.91	42.16	2.42	0.68	1.35	1.64	3.67	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	722.03	25.97	19.74	1.04	0.00	1.04	2.08	19.74	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	1051.23	21.32	18.50	1.41	0.35	0.35	0.53	19.03	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	1829.91	67.04	31.49	4.83	0.62	0.47	1.25	6.24	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	1265.86	51.25	37.05	6.90	0.54	1.22	0.95	12.98	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6625.31	57.17	88.22	9.88	1.76	2.47	4.94	48.34	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	1787.69	43.87	37.73	6.73	1.17	1.61	0.58	16.38	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	1615.51	43.63	37.91	7.50	0.95	2.18	0.95	12.68	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	1461.11	34.66	34.22	6.03	1.10	1.43	0.55	10.31	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	810.88	42.41	36.68	2.79	0.44	0.59	1.32	31.55	0.29
Fibroblast - Lung, donor1	11270-116H1	1464.02	40.78	24.47	4.08	0.00	0.00	1.36	6.80	0.00
Fibroblast - Lung, donor2	11347-117G6	581.94	49.24	29.84	8.95	0.00	0.00	0.00	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	1104.98	111.22	39.89	5.28	1.06	1.69	1.27	4.85	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	3915.20	125.79	134.12	5.83	0.83	0.83	2.50	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1672.76	65.74	62.94	2.80	1.40	0.00	2.80	6.99	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1895.60	53.46	48.70	3.36	0.84	0.28	1.40	2.52	0.84
Fibroblast - Mammary, donor1	11540-120B1	1871.92	105.15	99.06	11.37	1.62	2.44	2.44	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	1621.65	47.93	59.91	3.99	0.00	3.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	1882.18	89.34	65.52	11.91	5.96	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	370.10	84.18	51.02	6.60	2.13	2.13	0.78	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	409.84	88.58	62.19	9.10	1.97	1.37	2.12	1.67	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	406.66	51.10	59.06	4.90	2.14	1.84	1.53	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	1443.68	32.44	33.58	4.20	0.00	0.38	0.38	13.36	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	1773.03	25.11	19.17	2.16	0.81	1.08	0.54	13.23	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	954.00	20.30	15.19	0.81	0.00	0.12	0.81	16.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	1417.80	33.71	21.22	3.21	1.44	0.88	1.11	1.66	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	2037.80	71.93	76.40	5.28	1.83	1.22	1.63	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	546.59	69.49	39.42	8.02	2.00	2.67	2.67	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	730.63	65.63	33.21	2.77	0.00	0.79	0.40	2.77	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1549.88	3.77	4.56	0.40	0.00	0.79	0.20	1.79	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	1179.92	25.40	23.09	2.13	0.36	0.89	0.71	3.02	1.24
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	1414.68	36.26	22.07	3.35	0.20	0.20	0.79	3.15	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1248.55	5.42	6.02	1.81	0.30	0.00	0.00	1.81	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1430.79	37.68	30.66	4.10	0.76	0.54	0.43	7.23	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	2318.16	6.07	2.02	1.27	0.00	0.00	0.00	2.78	2.28
Fibroblast - skin normal, donor1	11553-120C5	2724.19	20.51	27.73	1.80	0.49	0.66	1.64	10.83	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1474.93	5.41	4.01	1.60	0.00	0.20	0.20	1.40	0.60
Fibroblast - skin normal, donor2	11561-120D4	4171.89	17.98	15.07	3.01	0.40	0.10	0.70	18.49	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	2117.48	3.93	1.81	0.60	0.00	0.30	0.00	4.23	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	1404.65	28.25	22.37	2.65	0.66	1.08	0.66	2.82	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	1362.65	47.52	21.71	1.88	0.17	0.51	1.37	10.09	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	2356.83	4.60	4.93	0.66	0.33	0.33	0.00	4.27	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	3729.54	17.90	19.60	3.30	0.96	0.53	0.53	18.32	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	2626.70	28.68	24.80	3.54	0.67	0.51	0.51	4.05	2.02
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1939.23	25.88	31.52	2.82	0.94	1.41	1.57	18.35	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2171.66	22.16	0.00	0.00	0.00	0.00	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	7913.50	7.84	14.82	0.87	1.74	2.61	0.00	114.17	11.33
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1399.17	9.88	16.99	2.08	0.69	0.69	0.35	7.80	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1687.40	15.35	24.72	2.60	0.52	0.26	1.56	7.03	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	1013.62	14.56	21.72	2.56	1.02	1.02	0.26	8.18	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	300.10	162.30	45.93	0.77	1.53	0.00	2.30	18.37	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	264.80	174.19	47.22	0.00	0.64	1.28	1.28	17.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	130.08	143.49	67.89	1.71	0.00	0.86	3.71	27.10	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	28.68	207.37	64.80	1.65	0.28	1.10	3.31	44.40	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	78.54	136.54	55.71	1.83	1.14	1.14	1.83	28.08	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	120.07	140.87	63.80	0.59	0.79	0.40	2.77	24.57	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	19.83	185.03	57.89	1.85	0.53	0.53	3.17	47.05	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	130.78	149.38	47.62	1.30	0.98	1.30	3.59	28.05	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	120.28	89.33	36.70	0.88	0.88	0.00	1.33	15.04	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	399.24	123.52	28.83	0.99	0.14	0.28	0.85	5.09	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	669.28	107.75	31.03	1.72	1.11	0.37	1.23	8.13	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	395.69	107.72	24.98	1.07	0.27	0.81	1.34	5.64	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	594.07	101.22	27.38	1.12	0.74	0.50	0.74	6.44	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	544.02	92.33	28.79	0.69	0.42	0.42	1.11	5.81	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	480.81	88.84	23.99	0.81	0.61	0.20	1.42	4.68	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	1027.03	76.44	32.86	0.91	0.23	0.23	0.68	11.64	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	830.48	63.78	19.31	1.25	0.37	0.00	0.62	12.08	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	717.81	62.08	28.20	0.87	0.87	0.44	1.53	6.56	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	949.67	112.87	44.32	2.95	0.59	0.89	0.89	13.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	643.62	104.75	30.68	1.91	0.64	0.00	0.79	8.42	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	692.15	84.90	34.63	1.34	0.45	0.67	1.56	9.61	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	853.51	85.69	35.89	4.84	0.20	1.41	0.40	7.66	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	757.45	96.53	33.59	3.56	1.02	0.34	0.68	7.63	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	889.12	83.88	34.58	1.60	0.27	0.44	0.62	5.94	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1902.67	128.30	39.65	5.20	1.14	1.77	0.42	8.53	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2191.06	127.74	46.45	9.39	1.20	2.22	0.85	9.22	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1057.63	83.32	28.99	2.32	1.00	1.22	0.22	10.73	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	727.14	80.62	32.20	2.58	0.50	0.58	0.58	4.41	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	861.64	76.16	35.53	3.47	0.82	0.61	0.41	4.49	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	1204.62	78.40	30.95	2.89	1.03	2.06	1.24	13.82	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	1067.85	82.09	22.48	3.34	1.04	0.58	0.46	9.92	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	974.41	71.71	29.35	2.84	0.50	0.50	0.67	10.34	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	1624.35	63.04	31.30	3.97	0.44	0.44	0.66	17.85	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	1749.32	67.77	28.66	2.83	0.86	0.61	0.61	20.05	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	754.06	71.81	31.93	3.24	0.49	0.97	1.46	5.02	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	1925.57	85.95	34.96	2.57	0.32	0.96	0.32	16.68	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	1251.70	57.89	25.49	3.22	0.76	1.14	0.57	14.69	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	1221.59	51.09	30.69	2.37	0.63	0.63	0.63	10.76	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	1594.33	53.52	29.80	2.74	1.22	1.22	0.91	15.51	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	1135.81	46.83	26.55	2.09	1.05	0.52	0.42	11.60	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	1463.77	46.77	31.18	2.20	0.66	1.10	0.22	14.05	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	1417.05	51.06	28.90	5.61	0.56	1.96	0.28	14.31	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	1172.98	22.50	13.70	1.85	0.37	0.65	0.37	7.13	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	1371.25	36.10	21.93	2.14	0.27	0.53	0.27	9.36	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	973.27	22.80	22.49	4.13	0.77	0.15	0.92	4.90	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	1106.25	32.00	19.43	2.07	0.52	0.78	0.78	8.03	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	1644.06	37.41	22.77	1.08	1.08	0.81	1.36	15.18	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	1651.05	25.81	20.83	2.40	1.11	0.37	0.37	11.43	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	1870.30	31.14	16.01	2.85	0.66	0.22	0.00	15.13	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	3264.83	40.66	36.69	5.95	1.98	0.00	1.98	9.92	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	1435.34	21.90	16.62	3.30	0.40	0.92	0.26	6.60	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	1323.12	21.59	15.33	2.22	0.20	0.40	0.81	5.45	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	2375.12	63.03	46.26	11.69	1.02	3.81	1.27	2.03	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	345.57	124.21	33.04	0.20	0.60	0.00	1.19	3.98	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	384.73	106.31	26.66	0.31	0.62	0.15	0.92	3.39	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	259.41	149.55	30.89	0.41	0.20	0.20	2.05	2.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	131.12	122.98	30.04	0.63	0.31	0.63	0.63	4.07	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	145.80	116.13	25.71	0.85	1.13	0.85	2.26	2.83	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	117.61	110.23	23.52	2.31	0.46	0.00	1.38	2.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	180.66	106.42	22.27	0.00	0.00	0.00	0.00	12.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	103.28	104.44	33.65	0.39	0.39	1.55	2.32	5.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	181.30	104.29	41.72	4.81	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	99.11	139.11	34.78	0.00	0.00	0.00	0.00	5.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	77.79	99.92	26.69	0.65	0.33	0.00	1.30	3.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	116.95	101.72	37.47	0.41	0.41	2.06	1.24	4.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	83.31	129.96	33.32	0.00	0.00	0.00	0.00	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	81.66	81.10	28.24	0.56	0.00	0.00	1.12	4.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	156.23	89.56	25.49	0.98	0.33	0.65	0.65	5.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	57.04	120.79	33.55	3.36	0.84	0.84	0.00	9.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	76.97	81.11	27.35	1.59	0.32	0.00	0.95	3.50	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	81.86	77.10	26.15	1.70	0.34	0.34	0.34	3.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	60.56	89.79	50.12	2.09	2.09	0.00	0.00	10.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	79.61	116.26	33.79	2.86	0.00	1.72	1.15	4.58	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	103.59	80.21	31.37	2.37	0.59	0.59	1.78	2.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	172.80	62.68	22.02	0.00	0.00	1.69	0.00	6.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	202.13	80.77	18.64	2.07	0.41	0.00	1.24	4.14	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	130.25	88.83	29.23	2.53	0.69	1.38	0.23	4.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	263.42	73.76	10.54	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	184.90	58.43	19.61	0.77	0.38	0.38	0.77	3.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	245.78	66.82	19.56	0.33	0.65	0.00	0.98	6.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	343.78	82.94	20.07	3.34	0.67	0.00	0.00	14.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	348.67	119.82	40.07	5.78	0.77	1.16	0.77	7.71	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	341.66	90.72	27.04	3.42	0.00	0.34	0.68	5.82	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	395.08	104.36	32.30	0.00	2.48	0.00	0.00	9.94	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	326.52	98.14	27.84	5.66	0.00	0.47	0.47	8.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	372.96	115.27	33.19	2.41	1.81	1.21	1.21	3.62	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	256.37	78.84	26.45	1.02	0.00	1.02	1.02	10.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	328.64	109.28	31.51	4.39	1.20	0.80	0.80	9.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	323.15	103.11	27.13	3.95	0.00	0.49	0.49	3.95	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	236.09	70.83	28.33	3.54	0.00	0.00	0.00	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	376.91	81.10	28.59	5.83	0.58	1.75	1.17	5.25	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	365.59	84.27	33.36	3.51	0.44	1.76	0.00	6.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	522.18	58.49	14.41	0.00	0.00	0.00	0.00	4.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1197.41	38.20	17.31	1.79	0.60	0.00	0.00	4.78	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	821.52	67.93	25.23	2.91	0.00	0.00	0.00	8.25	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	910.76	28.53	18.26	3.42	0.00	0.00	0.00	6.85	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	1331.03	36.18	19.13	0.00	0.00	0.42	0.00	9.56	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1480.91	16.87	12.37	6.75	1.12	1.12	0.00	9.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	1814.80	32.67	12.37	2.54	0.32	0.00	0.00	4.44	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2267.09	40.52	27.99	1.67	0.42	1.25	1.67	5.01	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	1078.84	71.48	86.68	9.98	3.48	3.13	4.29	2.44	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	1144.98	62.12	87.27	9.45	5.40	2.87	2.36	2.70	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	916.38	69.84	87.59	9.33	5.92	2.96	3.87	2.05	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	1092.54	73.35	83.40	12.02	5.68	4.26	2.51	3.83	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	1070.48	57.81	84.46	9.46	5.80	1.93	4.94	2.15	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	844.55	55.11	77.07	12.49	3.23	4.95	3.23	1.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1134.41	81.70	88.80	9.96	4.11	2.86	4.73	3.11	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	1072.53	57.47	83.03	8.58	3.43	2.74	2.23	1.72	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	824.96	62.15	88.42	7.05	7.05	2.88	1.92	1.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	2587.70	97.37	63.24	2.80	0.56	0.56	2.24	54.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2208.98	59.29	33.33	2.16	0.43	2.16	1.73	14.71	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2776.00	118.97	76.67	5.29	0.00	0.00	2.64	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1857.43	72.31	32.10	2.12	0.35	1.06	1.41	2.47	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3384.09	59.57	29.79	2.91	0.73	2.18	0.00	9.44	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	1087.67	41.44	25.18	1.92	0.35	0.35	1.05	2.27	0.17
Hepatocyte, donor1	11523-119I2	753.00	21.79	12.11	0.00	1.21	0.00	3.63	2.42	0.00
Hepatocyte, donor2	11603-120I1	1019.16	31.24	35.55	0.00	1.08	0.00	2.15	5.39	1.08
Hepatocyte, donor3	11684-122I1	209.83	23.93	20.25	1.23	0.61	0.00	0.61	7.98	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.65	38.51	98.56	47.65	24.15	13.71	1.96	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	221.27	12.76	8.91	0.70	0.17	0.35	0.35	0.52	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	695.78	90.83	48.71	4.80	0.14	1.23	3.02	0.96	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	525.34	111.44	57.31	19.10	3.18	6.37	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	460.60	200.26	66.75	26.70	6.68	6.68	0.00	13.35	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1164.58	27.08	0.00	0.00	27.08	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	454.08	128.75	41.53	29.07	2.77	4.15	1.38	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	515.55	140.15	62.57	22.52	2.50	7.51	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1590.35	118.68	71.21	23.74	11.87	0.00	0.00	23.74	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	489.52	115.33	33.32	23.07	0.00	0.00	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	498.21	141.69	77.70	13.71	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	804.04	116.95	55.23	22.74	3.25	4.87	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	496.86	133.38	63.36	38.35	3.33	1.67	0.00	6.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	399.36	98.03	58.09	36.31	3.63	7.26	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	725.26	123.08	67.50	14.56	3.97	5.29	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	472.28	127.49	65.41	25.50	4.43	3.33	0.00	5.54	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	466.21	130.96	52.38	5.24	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	563.73	141.72	47.24	16.38	0.63	6.93	1.26	3.78	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	467.08	117.54	43.31	17.01	4.64	6.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	263.43	58.54	73.17	0.00	14.63	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	661.54	146.00	62.02	20.03	2.58	6.46	0.00	2.58	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	534.50	104.65	57.96	19.32	3.22	11.27	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	370.39	47.79	0.00	23.90	0.00	0.00	0.00	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	703.24	153.20	58.67	33.41	2.44	6.52	1.63	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	586.06	158.27	55.00	23.93	3.36	7.14	1.68	2.10	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	244.33	43.12	28.74	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	669.47	149.49	50.63	18.48	4.82	7.23	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	468.10	127.41	60.94	26.78	2.77	7.39	0.92	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	226.21	75.40	15.08	0.00	15.08	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	610.82	153.88	59.48	16.99	8.02	3.30	0.47	3.78	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	464.37	121.54	57.14	27.21	2.72	4.53	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	339.08	44.23	44.23	14.74	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	686.56	148.50	47.35	21.52	3.23	9.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	580.60	104.18	73.69	22.87	1.27	10.16	1.27	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	361.47	115.01	49.29	0.00	0.00	16.43	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	626.20	118.61	42.09	17.22	3.19	5.74	1.91	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	552.27	142.17	40.10	25.52	3.65	9.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	410.91	31.61	31.61	15.80	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	623.38	134.24	54.98	22.14	1.43	3.57	2.14	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	474.52	96.23	36.50	23.23	0.00	6.64	0.00	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	291.88	83.39	0.00	0.00	0.00	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	595.10	154.64	58.65	16.05	4.32	4.01	1.23	3.09	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	502.22	122.92	63.22	15.80	1.76	3.51	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	625.48	132.01	72.29	6.29	9.43	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	596.64	123.78	50.07	20.86	2.78	4.87	1.39	1.39	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	509.01	223.52	86.31	15.49	4.43	33.20	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	677.58	139.41	74.57	25.94	0.00	6.48	12.97	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	659.18	166.54	53.19	14.82	2.62	4.36	1.74	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	404.96	227.23	96.74	22.50	9.00	9.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	491.32	149.84	76.66	13.94	3.48	13.94	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	550.46	181.35	83.21	22.40	6.40	11.73	1.07	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	529.24	162.10	60.96	34.64	2.77	6.93	0.00	5.54	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	481.58	125.38	48.44	25.65	2.85	8.55	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	647.98	151.87	67.19	20.25	2.76	5.52	0.00	3.68	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	172.44	178.49	90.76	15.13	3.03	6.05	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	211.10	130.38	68.30	6.21	0.00	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	197.73	180.81	70.84	11.63	9.52	7.40	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	7670.98	17.71	31.50	3.51	1.96	2.04	1.47	27.83	7.75
Keratinocyte - epidermal, donor2	11349-117G8	829.84	11.71	19.33	1.76	0.00	1.76	0.59	1.76	0.59
Keratinocyte - epidermal, donor3	11421-118F8	434.38	16.85	33.98	3.12	1.42	1.61	1.23	1.42	0.28
Keratinocyte - oral, donor1	11251-116E9	2811.83	56.87	39.84	2.50	1.02	1.02	1.02	5.22	1.25
Keratocytes, donor1	11527-119I6	181.20	89.40	69.80	1.72	1.38	0.34	3.44	0.00	0.34
Keratocytes, donor2	11607-120I5	856.59	83.20	38.67	5.86	0.00	2.34	1.17	5.86	0.00
Keratocytes, donor3	11688-122I5	294.02	47.23	16.20	1.19	0.59	0.00	0.59	2.96	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	145.06	13.19	63.74	6.59	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	549.08	67.96	59.33	5.39	2.16	2.16	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	313.70	113.72	72.77	14.99	1.96	2.77	2.31	0.35	0.23
Lens Epithelial Cells, donor3	11690-122I7	1729.39	41.78	27.65	4.14	0.71	1.72	0.81	1.21	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	2357.43	77.67	42.45	4.27	0.24	1.30	2.02	7.11	5.93
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	2304.88	60.56	26.79	1.12	0.84	0.56	2.79	5.30	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	1912.08	46.59	24.56	2.20	0.31	0.47	0.79	5.51	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	2387.99	72.59	35.49	2.15	0.00	0.00	2.15	5.91	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2413.22	74.06	30.89	1.26	0.00	0.63	1.26	4.10	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	2328.03	60.16	27.49	3.23	0.22	0.22	0.86	8.63	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	2197.24	60.74	32.42	3.28	0.82	0.82	1.23	3.69	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3210.30	77.62	34.64	2.28	0.76	0.51	1.77	6.57	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	2391.63	54.05	25.34	1.83	0.56	0.99	0.99	8.59	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	2172.66	60.12	28.87	3.16	0.00	1.19	1.58	4.75	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	2710.88	70.57	32.57	2.13	0.78	0.00	1.36	6.59	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2440.81	59.25	26.11	2.41	0.19	0.74	0.93	4.63	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	2282.87	70.73	34.49	3.83	0.00	0.70	0.00	8.01	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	3171.17	86.11	33.63	2.39	0.48	0.24	0.95	7.87	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2379.14	49.17	25.82	2.06	0.41	0.55	1.10	7.69	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	2384.52	67.44	34.49	2.77	0.00	0.31	0.92	6.78	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2832.82	77.94	23.07	2.81	0.31	0.31	1.25	5.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2833.98	57.09	30.74	2.20	0.73	0.91	1.10	8.42	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	2515.39	76.35	31.59	1.97	0.66	1.32	0.33	4.94	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3089.51	73.51	30.17	3.51	0.59	0.59	1.46	8.49	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3069.29	62.98	31.61	3.98	0.75	0.50	0.25	6.97	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	2242.47	65.96	33.46	2.91	0.00	1.45	1.45	5.82	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	2650.14	63.55	28.55	2.96	0.54	0.27	1.35	7.27	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	2617.02	55.71	26.04	1.36	0.61	1.06	1.21	10.14	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	2506.01	68.95	30.07	2.59	0.52	0.52	0.52	5.18	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	2670.78	72.24	28.27	2.93	0.63	0.63	0.21	5.65	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	2570.16	46.62	25.26	1.50	0.45	0.30	0.75	7.22	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	2696.47	72.23	41.96	3.44	0.00	0.69	0.69	7.57	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	2854.97	65.10	29.92	3.76	0.19	0.94	1.32	8.47	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2681.18	50.15	26.83	1.80	0.74	0.42	0.42	11.03	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	2513.99	64.45	27.62	2.42	0.00	0.00	0.48	3.39	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3132.24	67.15	29.77	2.65	0.33	0.33	0.66	8.27	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2841.33	54.26	26.76	2.48	0.25	0.87	0.25	7.81	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	2542.23	77.37	31.47	2.22	0.00	1.48	0.74	8.14	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	2761.39	64.98	25.20	4.69	0.25	0.25	0.99	6.42	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2870.18	53.90	27.09	2.34	0.14	0.55	0.82	8.39	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	2534.19	69.47	30.56	2.89	0.32	0.00	0.96	5.79	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	2835.44	76.69	21.91	1.52	0.91	0.00	0.91	7.61	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	2650.54	56.97	28.13	3.64	0.56	0.42	0.98	8.12	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	2419.95	67.56	30.93	3.56	1.07	0.36	0.36	4.27	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3513.66	74.66	23.75	1.45	0.00	0.48	0.97	5.33	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3187.31	59.91	28.94	1.40	0.31	0.31	0.78	8.40	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	2629.93	64.10	26.50	3.94	0.00	0.72	0.72	5.01	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	3082.50	70.89	31.36	3.27	0.00	1.31	0.65	12.09	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2830.97	51.32	24.25	0.94	0.71	0.24	0.47	7.53	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	2664.99	67.57	39.11	3.59	0.12	0.50	1.24	6.31	2.97
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3152.16	67.87	33.81	3.07	0.00	0.00	1.79	8.20	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2731.16	49.53	25.96	1.79	0.00	0.00	1.19	13.13	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	14577.23	174.48	129.16	2.27	6.80	9.06	18.13	22.66	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13233.03	205.59	147.29	8.44	6.90	6.90	14.58	38.36	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	12809.36	133.60	146.22	6.68	8.16	5.20	11.13	46.76	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15839.40	206.49	146.83	6.77	8.89	6.77	6.35	38.50	7.19
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14034.11	196.93	146.29	8.44	9.85	9.14	13.36	48.53	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	15459.93	185.86	198.00	10.27	6.54	13.08	5.60	41.09	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12990.96	154.07	113.36	7.73	5.67	4.12	5.67	41.22	6.70
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	13400.45	204.59	145.11	5.95	5.95	13.08	22.60	46.39	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13220.97	230.94	137.07	6.56	7.69	8.82	10.18	17.87	5.43
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	11898.34	175.37	146.87	5.82	5.82	6.98	7.27	37.81	4.07
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12403.66	187.27	158.46	6.75	9.45	7.20	16.21	40.97	3.60
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15541.05	236.15	150.39	9.48	9.48	7.86	8.94	30.62	5.83
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14175.82	147.38	127.35	5.14	8.22	7.70	6.68	38.00	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12013.66	166.55	142.91	6.70	6.00	6.35	12.35	38.81	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13815.17	146.59	156.58	7.33	8.66	4.66	16.66	33.98	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12854.35	166.57	123.78	10.70	5.09	6.11	9.17	41.26	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	11659.67	173.96	151.55	8.54	6.94	8.54	12.27	36.02	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11328.19	189.51	157.58	6.42	4.72	6.80	12.28	27.40	2.83
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	13474.45	170.57	111.67	10.43	4.91	3.07	5.52	35.59	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	14473.76	184.29	172.87	8.15	6.52	9.79	11.42	44.85	4.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11211.61	176.80	147.02	8.12	10.62	6.87	12.91	29.57	2.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11209.87	156.67	128.64	7.57	5.61	6.73	6.73	35.31	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	13273.88	200.92	124.67	11.33	7.21	5.15	13.39	44.30	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11368.01	156.47	138.18	9.87	9.00	9.58	9.00	32.51	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10846.97	144.08	128.24	6.58	4.19	5.98	5.68	29.00	3.59
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	10394.03	149.38	149.38	7.19	2.21	6.09	10.51	35.41	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	13446.65	190.88	135.74	8.84	7.07	9.19	8.13	35.70	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	12535.94	157.47	116.17	7.01	3.69	6.27	10.33	35.77	2.58
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12350.88	150.82	133.55	4.61	9.21	9.21	6.91	28.78	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13886.48	176.14	132.01	9.21	4.99	4.99	11.51	30.32	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13086.12	142.66	112.66	7.36	2.83	7.93	6.23	40.76	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13138.98	189.53	177.22	9.85	3.28	9.85	16.41	55.79	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13438.56	173.98	119.30	10.39	3.62	5.42	6.78	29.82	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	13882.44	163.74	140.76	10.77	5.03	4.31	7.18	35.91	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14619.90	209.13	189.71	8.96	5.23	11.20	14.19	43.32	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	12459.52	176.14	129.69	10.40	5.57	8.92	5.95	36.42	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12169.47	151.19	128.36	12.06	6.89	6.89	8.18	30.58	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13066.25	204.66	154.99	8.56	4.28	8.56	11.13	48.81	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14427.90	208.24	142.93	9.66	6.33	9.33	10.66	33.65	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15214.22	155.65	123.07	12.07	4.83	3.02	6.03	31.37	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	13104.40	164.95	124.42	8.53	7.82	4.27	12.09	49.06	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12997.34	172.89	118.24	6.19	6.19	6.19	4.81	35.75	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13918.40	157.27	119.69	11.27	4.29	4.83	4.83	32.20	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	13141.31	177.09	145.45	8.75	9.43	6.73	16.83	35.69	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13338.02	188.91	124.46	9.63	7.78	11.85	9.63	37.78	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	14084.25	195.37	97.69	8.14	5.81	6.98	4.65	17.44	10.47
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12687.63	157.60	118.47	6.35	5.29	1.06	7.40	35.96	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12729.60	164.46	132.05	6.00	5.20	8.00	5.20	29.61	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	14766.43	159.91	116.30	5.81	2.91	2.91	7.27	17.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	14097.78	199.29	134.14	11.50	5.37	10.73	9.20	33.73	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14990.71	211.62	153.90	7.40	6.91	3.95	10.36	41.93	4.93
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16104.04	159.02	98.80	4.70	3.76	3.76	6.59	32.93	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	13858.25	181.02	129.23	10.56	2.01	7.54	11.06	38.72	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13912.11	172.59	125.27	8.11	6.31	6.31	7.66	37.40	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15419.37	163.50	129.08	8.61	3.44	5.16	6.88	34.42	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	14351.62	206.19	146.07	11.13	5.79	7.57	11.13	45.42	8.02
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	14847.64	170.49	127.87	10.17	7.82	3.91	8.99	35.58	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	14749.70	157.68	129.31	4.62	3.96	6.60	4.62	34.31	5.28
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	14363.86	189.93	153.60	5.19	8.82	4.15	11.94	39.44	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14731.55	161.46	132.15	8.75	6.13	7.00	7.88	38.07	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12486.41	143.69	113.50	7.27	4.47	3.91	5.03	30.19	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	12908.75	144.42	130.28	8.83	6.62	8.83	9.72	34.45	3.53
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	13331.47	172.41	133.07	6.94	9.26	8.10	10.41	38.19	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13551.56	166.59	115.96	5.06	6.08	6.58	5.57	40.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12606.66	146.11	151.88	8.65	6.25	3.36	12.50	39.89	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	13753.12	164.58	121.65	5.57	6.76	5.57	5.96	33.39	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	13365.85	135.50	121.52	6.08	4.86	6.68	4.86	33.42	5.47
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12428.50	192.29	112.75	9.68	5.53	7.61	2.77	54.64	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	13363.14	186.58	126.16	8.36	4.94	8.74	11.02	40.28	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13570.41	147.70	131.17	5.16	4.13	4.13	3.10	28.92	4.13
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13273.99	192.88	132.42	7.86	8.47	4.23	8.47	49.58	6.05
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12451.35	162.57	133.42	13.31	7.61	8.56	9.51	33.27	3.49
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	13454.10	140.74	108.22	7.46	6.40	4.80	8.53	23.99	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	13369.71	174.70	107.46	13.79	4.02	5.17	5.75	55.17	3.45
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13268.27	157.87	126.50	5.14	8.23	7.20	6.69	40.11	7.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	15348.16	148.54	113.18	7.78	5.66	4.24	4.95	29.00	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13846.11	180.46	116.33	12.48	2.27	4.54	5.11	48.80	4.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	13799.13	173.90	124.81	9.57	4.58	8.74	9.15	22.05	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	15433.75	172.27	113.54	7.83	6.26	5.48	7.83	33.67	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14445.04	186.64	131.11	10.44	3.76	4.18	8.77	45.51	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14161.22	170.99	114.30	7.90	6.04	6.97	6.50	25.09	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14938.50	161.91	128.46	10.70	4.01	6.02	8.03	28.77	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14366.92	194.08	126.71	11.23	11.23	4.28	6.42	48.65	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13741.28	170.12	110.72	11.31	7.27	7.27	7.68	38.39	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14002.29	165.20	120.23	11.93	2.75	7.34	0.92	33.96	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	15898.16	195.60	140.48	12.45	8.00	1.78	6.22	56.01	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	14198.29	164.69	141.33	9.12	9.12	6.27	6.84	44.45	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14322.61	152.61	123.47	9.20	1.53	8.44	9.20	25.31	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	14511.12	210.66	158.13	13.68	9.30	6.57	6.02	59.10	4.92
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12901.94	165.71	150.12	7.13	7.13	4.45	8.02	30.74	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13380.15	204.06	132.32	11.44	9.62	8.84	6.50	25.74	3.90
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	14211.04	189.65	143.23	11.94	7.96	1.99	6.63	54.37	3.32
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	19225.06	245.28	176.68	12.47	10.39	6.24	4.16	47.81	2.08
Macrophage - monocyte derived, donor1	11232-116C8	294.69	7.75	16.18	0.46	0.46	0.00	0.00	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	582.64	8.07	6.97	1.47	0.37	0.00	0.18	0.37	0.37
Macrophage - monocyte derived, donor3	11389-118C3	426.14	13.63	17.30	2.75	1.05	0.39	0.39	1.44	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2838.84	23.36	27.61	2.12	1.59	0.53	0.53	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	3185.68	9.82	22.34	2.54	1.11	1.11	0.79	8.71	0.32
Mallassez-derived cells, donor3	11930-125I4	2774.33	24.32	30.02	3.47	1.67	1.11	1.53	6.95	0.00
Mammary Epithelial Cell, donor1	11273-116H4	1048.95	7.07	25.01	3.39	1.69	2.29	1.49	0.90	0.10
Mammary Epithelial Cell, donor2	11350-117G9	447.64	3.47	21.43	2.32	0.00	0.29	0.58	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	537.27	6.24	14.47	1.75	1.25	0.50	0.00	2.00	0.75
Mast cell - stimulated, donor1	11487-119E2	149.82	9.49	111.86	47.46	11.52	9.49	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	91.16	7.25	51.37	32.33	4.76	4.87	0.00	2.70	0.00
Mast cell, donor2	11565-120D8	680.23	17.83	68.65	22.59	4.46	2.67	0.30	8.32	1.19
Mast cell, donor3	11566-120D9	319.45	6.53	52.90	20.94	6.30	3.15	0.00	6.98	0.68
Mast cell, donor4	11567-120E1	1376.12	16.67	65.60	30.49	5.14	3.19	1.42	19.50	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	224.00	5.88	38.59	48.46	6.88	5.43	0.22	3.44	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	208.37	8.17	39.11	28.60	5.25	3.50	0.00	6.42	0.00
Mast cell, expanded, donor5	11939-126A4	118.28	5.51	48.99	27.30	5.28	3.67	0.34	5.16	0.57
Mast cell, expanded, donor8	11941-126A6	84.86	7.03	39.50	22.09	4.85	5.69	0.00	4.18	0.17
Melanocyte - dark, donor1	11502-119F8	2890.41	194.72	81.59	3.68	1.09	0.90	3.98	5.17	0.10
Melanocyte - dark, donor2	11582-120F7	1054.86	69.22	28.72	0.69	0.00	0.35	1.04	1.73	0.69
Melanocyte - dark, donor3	11663-122F7	997.37	32.74	28.54	3.91	0.94	0.65	0.72	1.59	0.07
Melanocyte - light, donor1	11274-116H5	1067.23	24.45	20.69	6.11	1.88	0.71	0.24	8.93	0.00
Melanocyte - light, donor2	11351-117H1	1599.70	25.93	18.43	2.73	0.68	0.68	0.68	12.97	0.00
Melanocyte - light, donor3	11423-118G1	748.41	24.28	22.55	6.07	0.87	0.00	0.00	4.34	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	774.38	34.15	26.55	4.17	1.87	0.62	0.21	6.25	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	633.90	26.63	14.79	4.30	0.27	0.54	0.27	4.30	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	973.38	49.02	35.09	5.89	0.80	0.54	0.54	11.79	0.00
Meningeal Cells, donor1	11493-119E8	540.53	66.00	65.75	10.05	1.74	1.49	1.36	0.87	0.25
Meningeal Cells, donor2	11573-120E7	259.25	59.86	62.06	12.76	0.88	2.20	3.08	0.88	0.44
Meningeal Cells, donor3	11654-122E7	569.70	58.27	45.15	10.19	0.82	2.77	0.65	0.65	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	377.26	82.12	51.90	6.56	3.14	3.71	1.71	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	680.78	35.62	20.23	3.02	0.30	0.70	1.31	2.31	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7895.50	130.10	59.14	6.57	1.31	1.31	2.63	23.65	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1794.80	79.80	57.56	10.47	0.00	0.00	1.31	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	1184.77	35.88	25.12	5.02	0.00	1.44	0.72	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	2156.22	15.46	22.02	5.08	0.00	0.42	0.85	18.21	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	2375.50	18.60	27.65	3.52	0.50	1.01	0.50	20.11	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	963.18	74.06	51.64	9.23	1.10	1.32	1.32	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	561.82	57.72	48.95	9.50	1.46	4.38	2.19	6.58	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	747.00	59.33	48.08	8.39	1.64	2.86	2.46	1.84	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	662.06	62.33	43.21	5.26	0.28	0.83	0.97	0.97	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1590.98	55.39	24.53	1.86	0.00	0.37	0.37	4.83	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	1017.86	53.68	25.39	2.24	0.66	0.26	0.39	1.58	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	995.27	99.11	24.04	0.59	0.30	0.30	1.19	3.56	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	894.51	79.41	35.03	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1658.00	124.88	46.11	1.92	0.64	0.64	1.28	2.56	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	873.71	40.76	24.81	6.73	0.35	0.35	0.35	2.48	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	758.36	49.41	22.20	2.19	0.31	0.00	0.63	1.25	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	930.34	89.99	33.38	3.63	0.73	1.45	2.18	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	633.50	24.13	64.44	6.36	1.86	1.06	2.39	4.51	0.27
Mesothelial Cells, donor2	12156-128G5	1162.58	38.54	77.07	7.01	3.00	1.00	3.00	5.00	0.50
Mesothelial Cells, donor3	11402-118D7	613.74	25.51	43.58	2.46	0.79	0.79	2.75	2.96	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	378.09	8.10	10.80	5.40	1.35	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	431.23	10.34	14.53	1.23	0.99	0.25	0.00	1.72	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	708.76	10.60	9.13	2.36	0.29	0.29	0.00	2.36	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	290.39	0.00	17.29	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	300.03	9.61	13.95	2.79	0.93	0.62	0.00	1.55	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	595.13	10.16	8.50	1.24	0.00	0.41	0.00	1.87	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	213.08	6.95	11.58	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	467.99	10.76	12.26	1.75	0.75	0.00	0.00	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	769.90	13.96	7.91	0.47	0.00	0.00	0.47	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	291.99	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	499.71	8.94	9.55	0.61	1.22	0.00	0.00	1.02	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	669.57	11.09	11.09	1.98	0.00	0.00	0.00	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	162.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	469.02	13.27	10.62	0.88	0.00	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	822.56	10.26	9.88	1.14	0.38	0.00	0.00	1.90	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	205.28	6.58	9.21	0.00	0.00	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	426.15	8.91	10.40	1.91	0.42	0.21	0.21	1.49	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	420.82	9.21	4.60	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	369.59	4.17	6.56	1.49	0.89	0.60	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	342.04	10.06	10.06	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	395.17	8.28	7.78	2.26	0.25	0.25	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	600.11	8.79	6.89	0.71	0.95	0.24	0.00	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	162.55	5.53	7.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	376.45	6.45	7.14	0.92	0.69	0.00	0.23	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	550.67	6.73	5.05	1.05	0.42	0.00	0.00	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	387.07	8.97	10.80	1.83	0.82	0.41	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	361.50	9.01	9.23	1.72	0.64	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	501.49	6.89	7.78	1.11	0.00	0.67	0.00	1.78	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	72.23	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	307.94	5.69	6.35	0.44	0.00	0.22	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	427.87	6.08	3.04	0.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	203.81	3.31	4.97	3.31	1.66	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	325.61	5.71	6.25	1.09	0.00	0.27	0.00	0.54	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	516.12	5.88	5.88	0.88	0.29	0.00	0.00	1.47	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	198.44	5.45	5.45	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	383.96	5.77	6.25	1.44	0.00	0.48	0.00	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	479.47	8.40	8.40	1.20	0.00	0.00	0.00	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	175.52	5.48	2.74	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	455.53	8.01	5.51	0.50	0.00	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	727.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	130.46	6.12	6.12	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	274.14	5.26	6.13	0.00	0.00	0.00	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	205.28	0.00	5.52	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	149.21	5.76	4.48	1.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	278.66	4.96	5.70	0.74	0.00	0.00	0.00	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	274.88	4.18	4.87	0.00	0.00	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	132.59	2.21	2.21	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	345.29	3.42	5.13	1.37	0.00	0.34	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	281.39	2.63	3.50	0.44	0.00	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	208.09	4.62	4.62	0.36	0.71	0.36	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	423.07	4.49	5.05	0.28	0.00	0.28	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	285.54	2.91	2.08	0.00	0.42	0.00	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	247.08	4.66	5.24	1.17	0.00	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	424.44	2.41	2.71	0.60	0.30	0.00	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	373.15	2.50	2.50	0.42	0.00	0.83	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	223.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	387.89	0.92	8.31	0.00	0.00	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	486.60	3.41	6.26	0.00	0.00	0.00	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	479.90	4.42	3.04	0.14	0.14	0.00	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	597.60	2.59	2.07	0.78	0.00	0.26	0.00	1.81	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	484.31	5.15	5.15	0.00	0.43	0.43	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	285.20	3.81	1.27	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	494.55	2.67	3.47	0.80	0.00	0.00	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	416.37	2.10	4.19	0.90	0.60	0.30	0.30	2.39	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	347.34	1.41	1.98	0.71	0.28	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	697.23	1.91	2.55	0.00	0.00	0.00	0.00	2.23	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	473.88	2.87	2.43	0.44	0.00	0.22	0.00	1.11	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	347.35	2.65	1.52	0.00	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	553.72	3.69	3.98	0.57	0.28	0.00	0.00	1.42	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	474.16	2.95	4.18	0.98	0.25	0.00	0.00	1.47	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	168.13	2.61	1.96	0.00	0.00	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	401.94	1.18	1.47	0.88	0.29	0.29	0.00	2.06	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	449.21	2.31	3.17	0.29	0.29	0.00	0.29	1.15	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	297.57	1.65	2.47	0.00	0.00	0.00	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	322.50	1.19	3.28	0.30	0.30	0.00	0.30	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	241.08	7.53	15.07	3.77	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	194.27	8.91	5.35	1.78	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	211.93	9.53	22.34	1.97	0.33	0.99	0.33	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	274.56	5.26	12.62	0.00	2.10	1.05	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	217.06	6.33	10.28	1.98	0.40	0.00	0.40	0.59	1.98
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	358.56	8.38	8.38	3.73	0.93	0.00	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	220.81	13.52	33.80	2.25	0.75	0.38	0.75	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	345.71	5.59	8.79	1.86	0.27	0.27	0.00	2.13	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	155.17	7.46	19.68	2.94	0.68	0.34	0.11	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	215.86	8.10	8.10	0.00	0.00	0.74	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	176.98	8.79	14.29	3.66	0.37	0.37	0.00	1.10	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	213.12	4.67	17.11	3.11	1.56	0.00	0.00	1.56	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	191.86	21.91	40.08	3.74	0.53	2.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	189.33	11.59	19.32	3.86	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	222.19	12.12	29.29	2.02	0.00	1.01	0.00	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	203.23	8.85	15.60	2.53	0.84	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1142.67	32.69	88.53	6.81	5.45	4.09	1.36	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	406.27	33.70	52.14	6.36	0.64	1.91	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	358.76	40.49	79.36	11.34	6.48	1.62	2.43	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	800.53	16.61	40.78	10.57	3.02	0.00	0.00	3.02	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	2541.02	34.26	45.68	0.00	0.00	0.00	5.71	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3712.67	35.89	48.94	6.52	0.00	6.52	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	1211.88	0.00	9.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	1907.46	12.55	37.65	12.55	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	1996.23	12.28	27.14	3.45	0.65	0.86	1.08	7.54	1.72
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	1270.99	12.02	31.36	5.75	2.09	1.05	0.00	8.88	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	700.19	26.70	27.37	4.00	0.67	1.33	2.00	3.34	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	819.30	21.70	14.61	3.34	0.42	0.83	0.00	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	389.22	23.77	29.85	11.79	1.71	2.47	0.95	3.80	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	576.10	46.28	59.05	6.38	1.60	1.60	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	442.64	10.20	12.92	3.40	0.00	2.04	0.68	2.04	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	290.35	69.83	34.92	9.19	1.84	1.84	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	461.64	24.27	18.83	4.19	0.84	0.84	0.00	4.60	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	544.14	19.99	22.08	3.72	0.70	0.70	0.23	2.32	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	658.54	32.16	24.32	5.13	1.08	0.81	1.35	1.89	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	1072.63	33.64	22.07	5.47	1.05	0.63	0.21	2.94	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	400.85	44.54	33.40	22.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	791.69	29.78	25.81	4.47	0.50	0.99	0.50	10.92	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	428.47	25.98	15.16	1.89	0.81	0.81	0.54	11.10	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	714.05	17.91	20.63	2.95	0.23	1.13	1.81	6.80	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	603.89	27.43	11.59	1.96	0.49	0.33	0.98	2.61	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	895.78	26.06	16.77	3.46	0.36	0.36	0.91	3.46	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	801.49	28.11	20.69	4.24	0.00	0.53	1.59	8.49	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	895.06	18.61	12.01	3.60	0.00	0.00	1.80	7.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	486.36	48.57	27.90	4.92	1.31	1.97	0.98	11.81	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	820.92	20.17	15.61	1.46	0.49	0.49	0.81	6.02	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	1310.70	31.22	17.46	3.53	0.88	0.88	0.35	2.29	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	998.59	24.61	18.28	2.81	0.00	0.00	0.00	7.03	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	681.29	15.17	10.11	0.46	0.00	0.00	0.00	3.22	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	538.57	22.49	16.39	2.89	0.32	0.32	1.29	4.82	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	756.34	36.90	40.35	3.45	1.03	1.72	2.07	22.42	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	748.42	96.08	55.63	5.06	5.06	2.53	10.11	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	1122.61	26.96	18.49	2.45	0.89	0.89	0.45	2.90	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	862.03	12.70	11.85	1.27	0.85	0.42	1.69	1.69	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	560.15	18.28	12.82	1.90	0.24	0.95	0.47	4.98	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	613.83	23.61	12.02	0.86	0.43	0.86	1.29	4.72	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	677.08	27.08	27.08	0.00	0.00	0.00	9.03	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	689.77	37.99	15.66	2.00	0.33	0.33	0.00	1.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	1413.45	27.95	32.91	2.25	1.80	0.90	1.80	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	901.93	18.25	11.51	0.79	0.40	0.00	0.79	1.98	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	661.20	12.07	11.14	1.86	0.00	0.00	0.00	1.86	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	496.05	22.70	17.03	1.51	0.00	0.00	1.14	4.54	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	991.34	22.81	20.53	2.61	0.33	0.65	0.98	4.89	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	659.78	35.30	18.74	0.87	0.44	0.87	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	1709.19	28.04	24.88	4.98	0.90	0.00	0.90	5.43	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	1131.49	9.70	15.87	4.41	0.00	0.00	1.76	7.94	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	680.80	20.61	8.64	2.66	0.00	0.66	1.33	5.32	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	808.55	33.73	16.37	1.49	0.00	0.00	0.00	5.95	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	967.78	22.97	22.20	1.53	1.91	0.00	1.91	3.06	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	389.25	17.54	6.65	0.91	0.30	0.60	0.60	2.42	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	1787.64	22.32	26.74	2.87	0.44	0.66	0.66	4.86	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	1063.92	18.97	18.97	2.03	1.36	0.00	0.00	5.42	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	572.27	61.31	30.66	0.00	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	631.63	16.46	18.29	0.00	1.22	0.61	0.00	4.27	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	1045.55	18.57	17.00	2.20	0.31	0.31	0.94	1.57	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	524.80	21.79	10.90	2.42	0.30	0.61	0.00	3.93	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	1364.72	11.08	18.20	1.58	0.00	0.00	0.00	4.75	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	777.68	49.88	41.94	9.07	3.40	1.13	2.27	19.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	379.34	45.52	20.23	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	3069.56	33.04	28.08	3.60	1.24	1.99	1.49	5.47	1.24
Myoblast, donor2	11322-117D8	916.36	44.11	19.75	4.41	1.92	1.15	1.92	4.60	0.19
Myoblast, donor3	11398-118D3	1530.95	24.22	16.65	2.52	0.50	1.35	1.35	2.86	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	5.54	4.31	50.74	20.60	7.07	4.00	0.00	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	15.98	2.11	48.85	20.51	8.14	2.71	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	8.28	4.23	42.52	14.91	5.52	4.97	0.00	0.55	0.00
Neural stem cells, donor1	11275-116H6	1152.70	47.91	46.09	7.62	0.73	2.18	0.00	8.35	0.73
Neural stem cells, donor2	11352-117H2	429.42	23.11	32.74	7.70	0.00	0.00	1.93	3.85	0.00
Neurons, donor1	11494-119E9	698.67	10.24	11.38	6.83	1.14	0.00	0.00	4.55	2.28
Neurons, donor2	11574-120E8	374.50	26.20	15.63	4.18	0.00	0.66	0.44	0.88	0.00
Neurons, donor3	11655-122E8	429.99	12.33	7.40	0.82	0.00	0.00	0.00	3.29	2.47
Neutrophils, donor1	11233-116C9	1.86	0.00	0.00	1.86	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	23.21	0.00	1.83	0.61	0.00	0.00	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	328.07	64.35	28.85	4.04	0.83	0.95	1.42	0.71	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	985.60	112.66	49.17	4.23	0.33	0.65	1.63	3.58	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	220.01	61.57	37.50	2.81	0.40	0.60	1.60	1.60	0.20
Olfactory epithelial cells, donor1	11933-125I7	946.36	14.04	13.90	1.65	0.28	0.69	0.28	5.51	0.69
Olfactory epithelial cells, donor2	11934-125I8	929.99	26.92	34.16	3.04	0.43	0.29	1.16	5.50	0.58
Olfactory epithelial cells, donor3	11935-125I9	778.19	21.23	34.39	2.72	1.36	1.25	1.02	2.72	0.45
Olfactory epithelial cells, donor4	11936-126A1	1172.76	27.27	41.78	5.75	0.39	1.85	0.97	2.73	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	1724.21	27.08	36.11	3.01	1.20	0.00	0.60	4.21	0.00
Osteoblast - differentiated, donor1	11276-116H7	1661.14	22.12	21.48	4.89	0.64	1.91	1.91	9.15	0.21
Osteoblast - differentiated, donor2	11353-117H3	1526.06	25.15	29.72	3.43	0.00	0.00	0.00	41.15	0.00
Osteoblast - differentiated, donor3	11425-118G3	680.92	33.52	14.28	3.10	1.24	1.86	0.00	8.69	0.00
Osteoblast, donor1	11277-116H8	1236.92	64.10	35.76	5.86	0.59	0.78	0.39	1.37	0.59
Osteoblast, donor2	11354-117H4	1064.01	37.93	32.31	5.62	0.70	0.00	4.21	0.70	0.00
Osteoblast, donor3	11426-118G4	971.65	26.66	23.28	4.27	1.24	1.78	1.07	2.31	0.36
Pancreatic stromal cells, donor1	11249-116E7	1183.85	58.54	27.54	2.44	0.59	1.10	0.76	9.01	1.01
Pericytes, donor1	11491-119E6	445.73	76.66	55.30	9.68	1.00	0.89	1.22	3.00	0.78
Pericytes, donor2	11571-120E5	1083.84	56.59	33.50	4.30	1.81	1.13	1.36	9.96	0.00
Pericytes, donor3	11652-122E5	1184.28	47.61	45.78	4.07	1.02	1.63	2.03	4.27	0.41
Perineurial Cells, donor1	11499-119F5	704.46	37.18	36.73	7.12	1.13	1.02	1.47	1.02	0.11
Perineurial Cells, donor2	11579-120F4	1107.53	88.70	31.19	1.56	0.55	0.46	1.01	2.39	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	10.52	10.52	71.72	25.18	9.24	3.51	0.00	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	7.10	3.43	37.71	8.82	5.14	1.71	0.49	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	10.48	4.27	43.10	13.20	4.53	3.49	0.39	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	1866.93	8.61	30.37	4.78	2.87	1.67	1.20	17.22	0.72
Placental Epithelial Cells, donor2	11355-117H5	3149.23	16.63	49.90	3.33	2.22	1.11	2.22	21.07	0.00
Placental Epithelial Cells, donor3	11427-118G5	648.67	22.77	31.22	4.91	1.77	2.36	0.20	4.52	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4233.50	10.44	13.29	4.11	0.32	0.63	0.32	22.78	0.32
Preadipocyte - breast, donor1	11467-119B9	4534.93	18.95	19.13	1.69	0.38	1.50	0.56	16.51	1.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	3606.99	1.70	2.35	1.31	0.13	0.39	0.00	1.44	0.78
Preadipocyte - breast, donor2	11328-117E5	3811.32	13.73	10.13	2.93	0.23	0.90	0.68	18.91	0.68
Preadipocyte - omental, donor1	11468-119C1	5081.67	16.73	22.38	2.66	1.17	1.39	0.64	28.98	5.01
Preadipocyte - omental, donor2	11329-117E6	4248.60	12.66	14.84	3.06	0.00	0.87	0.87	14.84	5.24
Preadipocyte - omental, donor3	11403-118D8	5207.23	16.76	22.78	4.01	0.57	1.58	1.86	26.64	0.86
Preadipocyte - perirenal, donor1	11469-119C2	3928.21	20.67	22.64	1.97	0.00	0.98	1.97	11.81	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	1253.96	20.88	14.13	4.30	0.31	1.54	0.92	1.54	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	984.37	57.02	21.07	5.49	0.53	1.42	1.06	2.83	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	635.67	83.95	25.54	5.96	1.36	1.70	2.21	12.60	0.34
Preadipocyte - visceral, donor1	11280-116I2	736.24	70.33	29.06	7.92	1.30	1.68	0.84	4.19	0.28
Preadipocyte - visceral, donor2	11357-117H7	868.36	40.96	37.27	5.52	1.38	2.30	0.00	6.44	0.00
Preadipocyte - visceral, donor3	11429-118G7	608.03	41.38	18.70	5.54	0.84	0.84	1.04	8.05	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	206.82	2.26	2.56	0.60	0.00	0.30	0.00	4.07	0.75
Prostate Epithelial Cells, donor2	11331-117E8	4380.76	20.31	31.15	3.93	1.35	1.62	2.57	65.81	0.41
Prostate Epithelial Cells, donor3	11404-118D9	2911.53	8.08	29.39	1.22	2.33	1.96	2.14	61.24	0.24
Prostate Stromal Cells, donor1	11254-116F3	1613.74	63.78	24.83	2.05	0.80	0.80	1.25	5.70	1.25
Prostate Stromal Cells, donor2	11332-117E9	1973.54	58.27	36.94	3.23	0.72	1.61	1.61	9.14	0.72
Prostate Stromal Cells, donor3	11405-118E1	1730.46	50.16	32.33	2.50	0.63	0.31	2.71	17.73	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	412.43	88.69	69.71	4.01	1.09	1.82	1.46	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	383.57	37.91	44.64	4.92	1.32	1.11	0.90	0.21	0.14
Renal Epithelial Cells, donor1	11517-119H5	751.72	142.53	88.26	18.26	4.06	2.03	2.03	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	495.79	111.68	69.71	6.40	1.42	2.13	2.13	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	932.88	75.27	60.87	4.13	1.16	1.48	1.59	1.27	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	3087.66	85.79	55.15	2.72	0.68	1.36	0.68	11.57	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	1438.74	96.36	80.05	5.53	1.21	0.40	3.10	8.22	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	2040.28	57.94	38.85	4.44	0.67	1.11	1.33	5.77	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6657.09	66.54	66.54	3.99	0.67	3.33	1.33	27.28	0.00
Renal Mesangial Cells, donor1	11518-119H6	1023.19	101.90	91.78	7.04	2.86	1.98	3.96	1.76	0.88
Renal Mesangial Cells, donor2	11598-120H5	1198.79	104.08	58.94	2.51	1.25	5.02	1.88	5.64	0.00
Renal Mesangial Cells, donor3	11679-122H5	1158.19	122.34	63.53	3.88	1.94	0.55	2.77	8.04	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	780.04	87.77	66.03	7.25	1.61	2.42	1.07	1.34	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	576.88	47.65	40.06	3.37	1.69	1.27	0.84	3.37	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	391.09	115.32	60.94	6.17	2.89	1.74	1.74	1.35	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	536.19	215.72	73.12	3.11	0.52	1.30	6.48	1.30	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	699.53	188.17	50.88	4.55	0.28	0.28	2.84	3.41	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1283.32	200.68	81.30	4.12	1.03	0.00	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	1020.44	131.73	41.90	2.76	1.00	0.50	0.50	5.02	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	8527.03	27.93	38.49	7.35	4.68	3.07	0.80	73.50	1.87
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	75.94	4.47	10.72	15.19	1.79	4.47	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	76.50	6.60	21.46	29.17	3.30	7.15	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	97.45	2.90	25.52	29.58	2.32	8.12	1.16	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	41.35	4.68	10.92	14.43	1.43	0.65	0.78	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	46.77	5.86	9.43	12.02	1.19	1.59	0.30	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	48.97	4.91	10.26	11.15	0.67	2.01	0.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	38.70	3.72	7.94	11.66	1.36	1.86	0.74	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	49.88	3.26	8.74	15.73	1.17	1.40	0.70	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	58.48	6.47	8.55	16.41	0.69	1.39	0.23	0.46	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	41.89	4.52	10.54	11.23	1.23	1.51	0.41	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	41.45	3.93	8.47	12.25	0.45	0.76	0.30	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	41.93	4.12	6.63	10.03	1.43	2.15	0.36	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	45.33	5.16	9.32	11.62	0.72	0.86	0.29	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	51.19	5.37	8.59	12.99	0.97	1.61	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	44.70	6.64	9.96	13.50	0.66	1.77	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	45.88	5.74	8.22	16.44	0.38	1.15	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	42.11	4.47	9.88	10.99	0.84	0.84	0.37	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	66.14	6.01	11.46	17.48	1.13	0.75	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	46.85	5.57	11.28	14.47	0.93	0.53	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	45.85	6.52	8.86	13.24	0.68	2.24	0.29	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	49.46	5.92	9.36	11.08	0.95	2.29	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	42.93	5.02	9.29	13.56	1.60	0.75	0.43	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	48.77	2.24	10.37	11.21	0.84	1.12	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	49.90	5.98	12.48	10.77	1.03	1.88	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	42.30	5.47	10.58	12.58	1.46	1.28	0.55	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	44.52	6.87	8.71	11.90	1.35	0.37	0.61	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	48.36	6.31	9.13	11.82	0.94	0.81	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	48.83	4.48	11.32	15.57	1.42	1.18	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	48.21	5.56	9.72	15.48	1.19	1.79	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	51.45	7.25	11.46	12.16	0.94	0.70	0.00	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	46.03	5.39	10.99	14.31	2.28	1.66	0.83	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	52.87	5.97	10.84	10.18	0.88	1.55	0.66	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	52.64	5.22	10.03	14.62	1.25	0.42	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	42.13	5.38	10.36	14.67	0.94	1.35	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	41.21	4.60	11.24	14.13	0.51	0.85	0.17	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	49.55	5.40	10.41	11.18	0.77	1.54	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	61.21	5.85	14.44	18.05	0.17	1.03	0.17	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	39.92	5.08	10.15	11.80	0.96	1.78	0.27	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	48.92	5.58	10.67	10.51	1.15	1.97	0.82	0.33	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	87.77	10.23	26.76	26.08	2.22	0.68	1.02	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	77.09	10.21	19.09	24.12	2.81	2.37	0.89	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	103.69	10.40	18.93	20.26	2.67	3.73	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	70.10	8.16	14.24	14.24	1.24	1.11	0.41	0.55	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	136.43	10.48	13.33	19.76	1.67	2.38	0.48	1.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	215.45	11.08	21.77	27.41	2.82	4.23	0.20	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	147.76	6.87	13.47	21.10	1.79	2.07	0.38	1.98	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	195.64	11.18	23.06	15.02	2.45	4.54	0.70	2.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	102.15	9.07	18.13	11.48	2.42	5.14	0.00	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	197.78	9.42	21.91	27.41	1.96	2.45	0.61	4.41	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	112.95	7.57	17.03	12.95	3.20	3.64	0.73	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	151.50	6.69	18.25	12.17	3.65	3.65	1.83	3.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	183.25	10.85	22.60	26.82	3.01	4.52	0.30	2.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	194.75	11.99	20.81	18.55	3.85	4.98	1.13	5.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	195.60	7.49	21.87	21.87	3.59	5.09	0.30	3.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	137.44	9.56	17.95	18.18	3.54	2.60	0.35	7.32	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	149.41	9.18	19.21	16.22	4.06	6.40	0.00	5.98	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	150.85	7.21	24.04	16.83	0.60	2.40	1.20	0.60	0.00
Schwann Cells, donor1	11498-119F4	1021.41	58.68	45.33	6.96	0.94	0.94	1.13	3.20	0.38
Schwann Cells, donor2	11578-120F3	408.29	23.82	20.41	6.80	0.00	0.00	0.00	6.80	0.00
Schwann Cells, donor3	11659-122F3	806.00	31.99	24.98	7.01	0.66	0.22	0.66	1.97	0.22
Sebocyte, donor1	11220-116B5	7217.41	27.39	35.61	5.48	2.74	2.19	0.55	10.41	0.00
Sebocyte, donor2	11301-117B5	6964.55	18.84	27.57	2.76	0.92	1.84	0.46	35.85	0.00
Sebocyte, donor3	11378-118B1	6121.96	24.32	17.11	1.65	0.21	0.82	0.82	30.50	0.82
Sertoli Cells, donor1	11255-116F4	2029.33	14.91	36.45	1.66	1.66	0.00	0.00	8.28	0.00
Sertoli Cells, donor2	11333-117F1	2663.38	62.14	22.59	2.82	0.00	0.00	0.00	22.59	0.00
Skeletal Muscle Cells, donor1	11281-116I3	345.93	36.60	37.83	5.72	1.14	1.58	0.79	5.98	0.18
Skeletal Muscle Cells, donor2	11358-117H8	1324.25	26.02	19.52	2.89	0.72	0.72	0.72	14.46	0.00
Skeletal Muscle Cells, donor3	11430-118G8	574.36	33.44	27.59	10.87	0.00	2.51	0.00	3.34	0.00
Skeletal Muscle Cells, donor4	11451-119A2	809.19	81.69	41.16	5.03	1.10	1.10	2.04	3.77	0.79
Skeletal Muscle Cells, donor5	11455-119A6	893.06	73.13	38.80	3.42	0.89	1.34	1.34	6.09	0.30
Skeletal Muscle Cells, donor6	11459-119B1	667.63	54.17	31.86	7.08	0.62	1.08	0.46	1.85	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	1494.43	80.27	39.31	2.77	0.88	1.89	1.13	8.06	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	1390.50	93.46	37.67	4.00	1.14	1.57	1.85	5.56	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	851.22	57.84	36.81	6.45	1.39	1.69	1.29	2.18	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	2239.16	50.21	26.88	7.25	1.35	1.77	0.84	7.84	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	434.98	39.08	23.88	5.07	0.00	1.45	1.45	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	703.13	35.50	17.06	3.03	0.14	0.55	0.55	4.82	0.55
Skin - palm, donor1	10286-104F7	1055.64	13.43	10.74	2.69	2.69	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	1014.86	9.51	10.81	2.16	0.14	0.43	0.72	8.51	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	565.16	1.64	4.09	1.64	0.00	0.00	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	988.64	13.24	12.98	2.47	0.52	1.17	0.26	5.32	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	2075.53	10.70	19.04	2.36	0.97	0.97	0.70	24.74	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	782.33	7.45	14.91	0.98	0.70	0.84	0.56	8.02	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	462.64	4.65	3.59	1.27	0.42	0.85	0.00	1.06	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	2087.60	4.87	17.69	1.50	1.87	1.65	1.20	18.06	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	2533.78	54.62	79.00	9.26	0.62	1.54	2.16	18.82	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1077.42	3.33	8.67	1.56	0.00	0.44	0.67	8.67	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	740.66	26.45	28.22	6.47	0.00	1.18	1.18	3.53	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	610.38	21.22	19.45	1.77	0.66	0.88	1.33	1.55	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	1386.50	32.68	49.62	5.12	0.39	1.58	0.39	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	927.08	23.18	32.45	6.95	2.32	0.77	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	1019.77	98.07	18.01	2.00	1.00	1.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	1557.01	30.08	32.74	4.79	0.53	1.06	0.67	5.06	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	720.60	52.09	39.90	3.32	1.11	0.44	2.44	5.54	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	745.39	18.56	19.20	1.02	0.38	0.13	0.77	10.11	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	454.85	40.70	25.72	2.93	0.65	0.65	0.98	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	929.98	49.61	36.92	3.84	0.30	0.00	2.07	2.95	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	1400.44	31.04	26.05	1.57	0.57	0.57	1.14	5.13	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2348.37	60.84	39.53	5.04	1.63	2.11	1.95	2.44	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	1240.26	41.10	18.57	0.91	0.00	1.22	0.91	2.44	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	524.83	40.41	25.76	5.56	1.52	2.27	1.77	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	899.74	36.72	30.60	6.12	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1132.96	20.50	20.98	1.43	0.00	0.48	0.48	9.54	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	920.24	55.45	24.63	1.47	0.00	0.59	0.44	2.80	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	1197.16	63.50	35.30	2.58	0.22	0.86	1.08	4.30	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	877.55	61.30	27.60	3.46	0.73	0.63	1.89	3.36	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	1349.42	30.47	38.82	6.65	1.86	1.39	1.70	3.71	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	971.17	45.27	50.66	6.47	0.00	1.08	4.31	4.31	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	418.70	14.94	30.78	3.89	1.20	0.90	1.20	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2608.97	138.61	62.82	5.46	1.37	2.05	1.37	3.41	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	1470.06	108.92	31.18	1.26	0.24	0.94	1.65	1.57	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1356.84	30.59	62.10	10.87	2.11	2.82	1.51	19.63	1.31
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	601.19	32.08	31.63	1.14	1.14	0.68	1.59	3.64	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	771.07	24.76	32.00	2.42	1.81	0.60	1.21	3.62	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	1052.28	111.53	63.32	10.07	1.85	1.59	2.12	2.65	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	1410.82	35.95	29.83	4.39	0.80	0.53	1.07	20.77	2.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	1250.57	84.02	42.32	2.75	0.88	1.13	2.88	18.78	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	1365.21	34.24	14.71	2.03	0.51	0.76	0.25	11.16	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	922.58	30.31	30.61	6.48	1.81	0.75	0.75	2.56	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	926.46	27.01	31.51	5.25	1.50	0.00	2.25	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1558.41	56.86	38.77	3.88	2.58	0.00	1.29	16.80	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	464.14	20.46	28.83	5.12	0.00	0.93	1.86	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	1175.37	57.56	48.47	5.05	0.50	1.51	3.03	5.55	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	1405.89	25.07	29.46	1.25	1.57	0.94	1.57	19.74	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2116.91	55.46	49.56	5.60	0.88	0.88	1.77	7.67	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	900.96	67.81	43.65	6.50	1.83	1.67	2.50	0.58	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	1341.21	72.88	22.89	3.27	0.47	0.93	0.00	3.27	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	1668.44	18.71	19.29	2.45	0.58	1.01	1.15	4.32	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	1612.08	35.95	28.81	2.80	0.25	0.51	0.76	7.39	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	710.95	61.30	30.09	4.32	0.38	0.75	1.32	3.57	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	1084.28	77.42	41.36	5.59	1.40	0.84	2.10	2.10	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	1633.95	46.00	18.35	2.01	0.59	0.50	1.26	1.01	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	606.18	59.52	40.00	7.14	0.00	1.90	0.95	4.29	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	1538.19	20.80	25.69	2.69	1.47	0.98	0.98	4.65	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	3082.23	37.12	45.96	4.86	0.88	0.44	1.55	39.55	10.16
Smooth Muscle Cells - Uterine, donor3	11466-119B8	1153.05	65.83	52.37	7.02	1.46	1.17	2.93	2.05	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	629.92	46.45	25.46	0.97	0.78	0.19	0.00	14.77	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	2162.70	16.66	33.06	3.97	0.53	0.53	0.53	17.19	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1407.82	46.49	33.85	3.35	0.74	1.49	1.12	45.75	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	2108.23	46.71	62.52	5.75	1.08	1.44	1.08	17.61	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1643.50	23.28	34.07	5.11	0.57	0.57	1.14	5.68	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	1651.49	33.08	26.78	5.12	1.18	2.36	0.39	14.57	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	908.64	44.19	31.24	3.30	1.52	1.02	1.27	19.30	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	822.60	54.71	29.55	0.80	0.00	0.40	0.80	26.36	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	1454.66	33.86	25.08	1.67	1.67	0.42	0.42	36.78	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	1224.74	31.63	33.00	1.83	0.92	0.46	0.00	7.79	0.46
Synoviocyte, donor1	11291-117A4	6006.36	6.23	7.57	0.67	0.00	0.67	0.17	17.00	6.73
Synoviocyte, donor2	11368-117I9	667.48	30.34	13.24	2.01	0.17	0.84	1.01	7.54	0.34
Synoviocyte, donor3	11440-118H9	518.53	30.38	24.13	1.56	1.12	0.89	0.22	6.48	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	698.58	148.29	55.74	6.79	3.22	1.79	2.86	1.79	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	782.91	144.69	57.48	1.98	0.00	1.98	1.98	5.95	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	484.40	110.45	36.58	5.79	0.69	2.08	4.17	1.85	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	705.30	9.46	19.00	1.72	0.57	0.57	0.36	1.58	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	1203.76	14.69	23.58	3.87	0.39	1.16	1.16	2.32	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	630.50	8.02	8.59	1.72	0.00	0.57	0.00	4.58	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	8404.77	27.80	37.77	7.01	4.06	2.95	1.60	70.00	1.60
Urethra, donor2	10319-105A4	3560.89	14.39	26.98	3.60	1.80	1.80	0.00	3.60	5.40
Urothelial Cells, donor1	11520-119H8	4449.56	13.55	35.86	3.45	1.06	0.80	2.13	7.70	1.06
Urothelial Cells, donor2	11600-120H7	4693.42	18.43	31.64	2.40	1.60	2.00	1.20	20.03	0.40
Urothelial Cells, donor3	11681-122H7	8202.79	22.23	33.23	2.52	2.06	1.38	1.38	25.21	0.69
Urothelial cells, donor0	11216-116B1	2795.55	10.25	19.17	2.67	0.45	0.89	0.67	2.23	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	60.51	13.35	85.42	42.71	27.58	42.71	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	42.89	11.44	100.07	61.47	30.02	38.60	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	38.33	9.58	49.97	28.07	20.54	41.07	0.68	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	14.12	5.51	41.66	24.45	11.36	12.05	0.00	0.34	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	19.75	4.65	63.91	26.73	12.78	16.27	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	55.19	10.41	74.97	37.48	21.87	26.03	0.00	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	44.05	11.01	85.35	49.56	30.29	29.37	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	48.38	10.95	62.99	26.47	23.74	51.12	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	1210.79	60.08	29.48	2.10	0.62	0.74	1.11	4.07	0.86
Wilms' tumor cell line:HFWT	10597-108E3	305.37	24.64	34.32	0.00	2.64	1.76	0.88	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	577.07	19.83	27.65	5.87	1.68	1.68	0.84	1.96	0.28
achilles tendon, donor2	10292-104G4	489.77	6.20	10.33	0.00	0.00	0.00	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	833.45	19.89	112.18	44.62	14.02	5.10	0.76	0.76	5.10
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	360.33	45.51	48.06	22.52	6.97	5.34	0.46	0.93	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	469.02	377.61	467.83	47.84	26.35	18.28	6.65	3.56	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	71.29	212.52	83.81	32.38	20.41	5.44	1.36	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1.12	0.00	1.12	0.84	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	284.02	21.99	60.70	18.40	7.40	3.38	0.21	0.85	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	370.75	317.40	92.28	11.71	2.99	2.99	1.09	2.18	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	922.70	106.19	40.54	8.81	2.64	1.76	0.88	2.20	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	77.18	59.21	69.83	24.09	6.94	4.08	0.41	1.23	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	124.64	102.90	33.39	11.65	4.66	1.94	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	41.03	34.59	11.78	5.52	2.94	0.18	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	66.31	62.41	46.81	15.60	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	403.88	150.35	92.26	9.06	3.02	2.56	2.79	1.63	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	8.03	37.02	58.77	36.25	8.03	4.14	0.52	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	192.88	21.63	42.08	14.03	6.14	3.21	0.88	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	773.82	102.71	176.61	33.46	18.13	7.44	0.46	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	604.54	14.39	32.49	14.39	0.82	0.41	0.41	2.06	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1808.55	27.63	15.04	5.22	1.84	1.53	0.00	3.38	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	2017.91	43.10	32.00	2.99	1.71	0.43	1.28	2.56	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	2232.85	55.20	27.60	7.58	4.85	2.43	0.00	2.43	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	2333.40	53.68	40.20	6.74	4.57	1.44	0.48	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	577.78	136.98	213.83	28.51	16.48	8.69	2.67	2.23	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1487.62	138.42	168.44	14.68	7.00	4.67	4.67	3.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	107.78	131.93	74.33	9.29	9.29	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	154.43	430.15	239.93	34.28	6.03	7.16	10.92	2.26	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	424.79	91.15	61.93	17.88	3.93	1.31	1.74	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	138.71	204.32	26.24	7.50	1.87	3.75	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	310.39	11.07	24.73	12.95	3.06	2.83	0.94	1.18	0.24
adipose tissue, adult, pool1	10010-101C1	1927.98	16.44	10.24	4.50	0.47	0.93	0.31	20.48	0.47
adipose, donor1	10184-103D4	7.04	75.65	12.31	0.59	0.00	0.59	1.17	25.22	0.00
adipose, donor2	10185-103D5	133.01	220.20	57.58	2.43	0.81	0.00	3.65	47.85	0.00
adipose, donor3	10186-103D6	138.87	129.88	50.37	2.18	0.27	1.36	1.63	24.78	1.36
adipose, donor4	10187-103D7	84.07	86.68	28.60	0.00	0.00	0.00	5.20	12.13	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	489.40	15.78	76.38	98.64	13.73	15.78	2.05	1.10	0.32
adrenal gland, adult, pool1	10081-102A9	687.52	7.28	7.28	0.00	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.13	0.40	0.13	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	1026.17	104.69	65.03	14.65	3.22	3.22	2.50	6.43	0.71
amniotic membrane cells, donor1	12235-129G3	209.36	2.32	29.91	16.93	4.87	7.65	0.00	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	949.39	27.72	51.73	9.47	4.06	5.75	0.34	11.83	0.34
amniotic membrane cells, donor3	12237-129G5	176.76	4.42	75.42	18.56	15.61	9.13	0.88	1.18	0.59
amygdala - adult, donor10196	10167-103B5	703.18	3.56	7.11	5.93	1.19	1.19	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	912.25	7.71	18.05	8.52	1.42	1.22	0.61	2.03	1.42
amygdala, newborn, donor10223	10360-105E9	2184.18	23.24	32.60	9.04	0.97	4.20	0.32	9.68	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	32.98	14.52	9.55	3.44	0.38	2.29	0.64	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.22	272.03	192.60	13.46	6.18	5.52	9.49	1.99	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	135.29	33.07	23.38	29.06	2.00	4.34	0.67	0.00	0.33
aorta, adult, pool1	10052-101G7	7180.43	8.63	9.61	3.33	1.18	1.37	0.20	19.02	4.51
appendix, adult	10189-103D9	1234.60	11.64	32.99	6.99	5.05	3.49	0.78	6.60	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	248.32	70.85	41.96	23.04	2.41	5.16	1.72	2.06	0.00
artery, adult	10190-103E1	8289.36	17.66	2.72	1.36	0.00	1.36	0.00	72.01	0.00
astrocytoma cell line:TM-31	10425-106D2	355.65	27.38	25.64	2.03	0.72	1.30	1.01	0.87	0.14
b cell line:RPMI1788	10427-106D4	85.06	3.42	21.86	29.29	2.38	1.49	0.00	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	3392.07	7.21	17.20	1.39	0.28	0.55	1.11	9.99	3.61
bile duct carcinoma cell line:HuCCT1	10432-106D9	104.89	10.72	21.83	2.88	0.79	0.79	0.60	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	70.97	1.34	5.69	1.00	0.50	0.17	0.67	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	149.88	89.48	40.82	5.03	3.91	3.91	1.68	1.12	0.56
bladder, adult, pool1	10011-101C2	4256.13	15.86	17.06	2.72	0.98	2.28	0.33	23.47	2.28
blood, adult, pool1	10053-101G8	35.43	8.86	42.08	15.50	8.86	8.86	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	2143.44	16.27	24.83	4.28	0.86	0.00	0.86	2.57	0.00
bone marrow, adult	10192-103E3	770.65	24.97	42.51	8.10	0.67	1.35	0.00	2.70	0.00
brain, adult, donor1	10084-102B3	250.12	4.10	6.15	3.08	0.00	0.00	0.00	2.05	1.03
brain, adult, pool1	10012-101C3	351.22	4.45	6.46	4.45	0.33	0.33	0.22	2.12	0.11
brain, fetal, pool1	10085-102B4	203.03	2.67	5.34	0.00	0.00	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	6172.20	178.40	131.49	3.30	3.30	6.28	5.95	14.21	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	214.20	1.12	5.87	3.50	0.62	1.37	0.00	0.12	0.12
breast, adult, donor1	10080-102A8	4327.32	6.94	13.26	5.68	0.63	1.89	0.63	114.28	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1053.02	64.28	57.42	10.42	7.62	4.57	3.81	3.94	1.91
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	530.93	21.65	32.78	4.64	1.55	0.62	0.62	1.86	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	309.41	27.86	122.25	61.93	5.06	6.22	2.30	3.68	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	196.57	40.91	128.31	38.01	7.99	10.89	3.63	0.48	0.24
carcinoid cell line:NCI-H1770	10703-109H1	208.75	2.82	7.05	14.58	2.35	0.94	0.47	1.88	0.47
carcinoid cell line:NCI-H727	10735-110B6	89.25	47.58	36.31	12.25	2.63	3.83	1.97	0.88	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	167.64	40.25	51.97	30.74	2.54	5.07	1.27	1.90	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	117.92	15.70	11.98	3.73	0.53	0.27	0.53	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	770.23	1.15	5.76	5.76	2.30	1.15	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	843.16	5.35	12.72	5.52	1.34	1.00	0.00	2.51	0.67
caudate nucleus, adult, donor10258	10379-105H1	261.34	5.35	3.82	12.23	0.76	0.76	0.00	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	2681.56	29.30	34.06	8.79	1.83	2.93	0.37	21.24	1.46
cerebellum - adult, donor10196	10173-103C2	265.11	5.83	14.57	5.83	0.00	2.91	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	573.70	3.84	5.76	3.42	0.64	1.07	0.00	2.99	1.28
cerebellum, adult, pool1	10083-102B2	123.49	2.07	1.72	1.03	0.00	0.00	0.34	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	712.39	21.59	11.62	0.00	2.49	1.66	1.66	2.49	0.00
cerebral meninges, adult	10188-103D8	1171.94	9.83	10.84	5.80	1.26	1.51	0.00	2.02	0.00
cerebrospinal fluid, donor2	10294-104G6	1240.31	43.85	19.73	1.46	0.00	0.00	0.00	9.50	1.46
cervical cancer cell line:D98-AH2	10552-107I3	26.46	38.97	102.52	10.21	6.33	8.05	3.59	0.86	0.29
cervical cancer cell line:ME-180	10553-107I4	7075.27	19.55	33.31	2.32	2.49	1.49	2.15	16.07	2.32
cervix, adult, pool1	10013-101C4	4887.71	30.87	20.16	5.25	1.15	2.20	0.73	27.82	1.78
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	324.52	13.93	25.36	3.34	0.14	0.14	0.56	1.39	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	352.69	32.66	26.13	7.84	0.00	0.00	1.31	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	2.24	0.00	0.25	0.00	0.00	0.00	0.00	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	178.41	4.68	21.69	1.97	1.60	0.86	0.86	0.86	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	2.61	2.37	38.19	4.03	3.79	1.66	1.19	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	524.54	3.99	17.95	5.41	2.28	1.99	0.28	2.28	0.28
chorionic membrane cells, donor2	12239-129G7	1523.88	23.27	24.36	2.29	0.70	0.89	1.49	24.56	0.10
chorionic membrane cells, donor3	12240-129G8	757.19	4.95	15.94	3.30	1.65	0.00	0.00	6.59	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	21.21	137.33	161.57	31.30	9.09	11.11	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	332.71	28.81	32.08	9.22	3.07	1.92	0.96	1.92	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	19.85	92.50	64.41	12.04	6.12	4.01	2.96	1.06	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	509.49	154.08	131.23	40.57	7.96	10.79	2.82	1.80	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	528.50	174.64	127.23	33.86	9.68	9.92	3.14	1.21	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	595.97	173.27	120.94	31.56	9.77	12.42	1.63	1.43	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	140.16	78.33	57.42	20.61	6.18	5.59	1.18	0.29	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	48.74	72.98	84.70	19.81	6.78	6.52	1.56	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	309.96	25.14	63.77	18.52	2.29	3.20	1.83	5.49	0.69
clear cell carcinoma cell line:TEN	10636-108I6	1807.76	8.85	19.61	4.68	1.21	0.69	0.52	3.12	0.87
colon carcinoma cell line:CACO-2	10513-107D9	62.78	0.00	0.37	0.00	0.00	0.18	0.00	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	406.69	36.87	57.77	29.27	3.42	1.90	1.52	0.38	0.00
colon, adult, donor1	10082-102B1	1863.59	14.28	11.90	1.19	1.19	0.00	0.00	8.33	1.19
colon, adult, pool1	10014-101C5	1591.82	10.46	9.52	3.41	0.82	1.18	0.24	8.11	0.82
colon, fetal, donor1	10070-101I7	1784.75	8.03	14.83	3.71	1.85	1.85	0.00	18.54	0.00
common myeloid progenitor CMP, donor1	12130-128D6	13.75	100.84	50.42	18.33	4.58	13.75	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	275.40	250.37	25.04	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1126.50	45.04	61.19	21.67	6.80	3.40	2.55	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	736.55	89.65	73.65	23.39	8.00	6.64	0.75	2.26	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	786.56	114.50	83.76	28.91	9.73	5.36	1.13	1.41	1.13
corpus callosum, adult, pool1	10042-101F6	454.41	13.38	14.04	11.61	1.88	1.11	0.33	0.11	0.11
cruciate ligament, donor2	10295-104G7	1146.82	12.97	12.97	0.00	0.81	0.81	0.81	8.92	4.05
diaphragm, fetal, donor1	10069-101I6	4454.22	20.06	16.05	3.21	0.80	0.80	0.00	20.87	1.61
diencephalon, adult	10193-103E4	289.19	3.84	7.44	3.60	0.72	0.96	0.00	1.92	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	74.16	4.36	29.85	25.26	5.51	2.07	0.00	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	1299.89	40.77	118.22	5.64	2.56	2.56	2.05	1.54	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	589.29	96.29	68.61	5.30	2.41	6.02	2.41	6.50	0.72
ductus deferens, adult	10196-103E7	3004.49	10.47	15.95	1.50	1.50	0.50	0.00	7.97	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	966.39	5.76	21.60	7.20	1.44	0.00	0.00	8.64	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	1702.29	23.54	32.37	10.30	0.00	2.21	0.00	6.62	0.74
dura mater, adult, donor1	10041-101F5	673.75	30.47	20.23	3.72	0.66	0.83	0.66	1.49	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	106.37	36.86	50.63	6.66	1.11	3.33	0.44	4.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	123.81	92.85	57.17	19.20	2.44	4.01	1.00	3.01	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	112.84	36.38	90.64	3.70	3.70	2.47	2.47	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	357.50	18.47	64.17	13.02	3.33	2.72	0.61	1.82	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	154.99	43.22	107.44	9.26	3.40	4.94	2.78	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	210.15	38.09	109.02	10.51	2.63	6.57	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	452.18	73.41	56.98	3.69	1.01	1.01	1.01	2.68	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	608.04	21.20	71.41	13.77	6.52	5.07	3.26	3.62	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1459.86	4.34	21.71	5.47	0.48	1.29	0.48	3.38	0.48
epidermoid carcinoma cell line:A431	10426-106D3	1818.00	25.01	39.35	5.11	1.89	2.33	1.22	3.33	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	1654.40	30.80	78.64	10.78	5.94	5.83	2.64	2.31	0.11
epididymis, adult	10197-103E8	2163.02	19.47	17.16	5.65	0.42	1.67	0.63	18.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	2049.80	30.16	24.13	5.68	1.77	1.06	0.53	5.32	3.37
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1008.27	166.34	64.49	1.97	0.39	1.18	2.36	3.15	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	820.24	47.96	77.19	9.96	6.42	4.59	3.80	1.97	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	234.73	43.40	62.30	6.50	4.82	4.04	2.66	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	738.84	64.64	87.50	8.74	5.83	4.82	3.25	1.68	0.22
esophagus, adult, pool1	10015-101C6	11745.83	33.34	20.92	4.99	2.65	2.65	1.06	75.07	3.61
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2244.35	169.19	42.33	3.63	2.00	2.76	1.00	6.51	0.38
eye - muscle inferior rectus, donor1	10272-104E2	970.66	7.24	4.83	0.00	0.00	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	2541.88	14.73	6.31	0.00	2.10	0.00	0.00	6.31	0.00
eye - muscle medial, donor2	10299-104H2	1328.98	4.46	11.91	2.98	0.00	0.00	1.49	0.00	1.49
eye - muscle superior, donor2	10297-104G9	925.22	9.17	9.17	2.29	0.00	0.00	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	135.54	13.12	7.29	2.91	1.46	0.00	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	1422.19	34.07	23.14	3.81	1.27	1.27	1.53	6.10	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	0.00	1.15	1.28	0.51	0.00	0.13	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	69.56	23.03	33.48	5.70	0.71	0.00	1.19	0.71	0.47
frontal lobe, adult, pool1	10040-101F4	210.63	3.85	5.44	5.63	0.19	0.66	0.38	0.47	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	159.13	7.51	29.42	4.80	2.10	0.90	1.20	0.60	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	579.71	4.85	11.98	2.19	0.27	0.46	0.64	0.64	0.27
gall bladder, adult	10198-103E9	1615.67	14.24	14.49	5.55	2.90	0.97	0.24	15.93	0.72
gamma delta positive T cells, donor1	11937-126A2	8.05	4.29	60.13	36.51	12.35	3.76	0.00	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	29.13	6.35	38.47	25.40	2.61	3.36	0.00	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	831.14	15.84	39.08	6.34	1.06	1.69	1.90	4.65	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	266.91	17.02	51.06	6.96	4.64	6.00	1.55	0.58	0.19
gastric cancer cell line:AZ521	10549-107H9	168.87	19.67	114.11	47.22	10.00	10.33	4.10	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	692.83	19.22	34.78	13.73	1.83	5.49	0.92	4.58	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	829.30	111.49	88.18	8.22	2.51	2.28	1.14	5.48	0.69
giant cell carcinoma cell line:LU65	10487-107B1	44.75	8.03	33.39	10.44	4.70	5.16	0.46	0.34	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	528.63	122.32	49.27	0.84	0.84	0.14	2.10	1.96	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	3380.11	15.46	34.42	6.98	3.24	2.24	2.49	10.48	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	2987.24	119.59	103.12	16.99	2.22	4.43	3.91	2.85	1.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	2641.65	106.45	97.75	15.45	2.81	2.81	5.20	2.67	1.54
glioblastoma cell line:T98G	10485-107A8	967.20	83.11	25.05	2.98	1.21	0.88	0.77	0.66	0.22
glioma cell line:GI-1	10413-106B8	596.88	72.63	47.45	13.18	4.39	5.27	1.76	6.74	0.29
globus pallidus - adult, donor10196	10175-103C4	575.11	2.92	3.64	6.56	0.00	0.00	0.00	5.83	0.00
globus pallidus, adult, donor10252	10161-103A8	1073.77	10.50	27.09	13.18	1.95	2.44	1.22	4.15	2.20
globus pallidus, adult, donor10258	10367-105F7	195.80	4.11	10.95	5.48	1.37	0.00	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	1298.19	25.58	24.51	6.40	1.07	1.07	0.00	12.79	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	31.81	190.88	56.28	9.79	4.89	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	305.99	251.35	54.64	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	109.76	778.76	125.44	0.00	5.23	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	371.83	4.48	10.56	0.96	0.00	0.64	0.96	1.28	0.00
hIPS +CCl2, biol_rep1	14383-156B9	400.81	96.41	37.65	0.00	0.46	0.00	1.38	4.59	0.00
hIPS +CCl2, biol_rep2	14384-156C1	433.48	79.56	32.01	1.37	0.00	0.00	0.91	4.57	0.46
hIPS +CCl2, biol_rep3	14385-156C2	488.87	87.60	45.73	0.00	0.00	0.00	2.58	2.58	1.29
hIPS, biol_rep1	14380-156B6	382.32	31.62	50.31	2.87	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	315.50	53.50	38.41	0.00	0.00	0.00	1.37	0.69	0.69
hIPS, biol_rep3	14382-156B8	397.25	22.07	14.35	3.31	1.10	2.21	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	54.60	5.75	24.14	38.79	2.30	4.31	0.29	0.29	0.00
heart - mitral valve, adult	10205-103F7	4306.93	18.54	14.05	4.19	1.49	1.79	0.60	11.06	6.28
heart - pulmonic valve, adult	10206-103F8	4702.11	5.49	5.75	3.92	0.26	0.26	0.00	13.07	0.78
heart - tricuspid valve, adult	10207-103F9	3327.24	18.32	21.65	7.49	2.50	0.83	0.00	14.15	6.66
heart, adult, diseased post-infarction, donor1	10050-101G5	3919.72	5.10	9.59	4.49	1.63	1.22	0.41	12.24	1.02
heart, adult, diseased, donor1	10051-101G6	5870.95	4.68	7.66	1.28	0.00	0.00	0.00	11.50	0.85
heart, adult, pool1	10016-101C7	3552.46	8.51	6.67	3.22	1.38	0.23	0.23	8.28	1.15
heart, fetal, pool1	10046-101G1	7749.46	8.63	7.70	4.31	0.31	1.03	0.10	7.08	1.85
hepatic mesenchymal tumor cell line:LI90	10778-110G4	2678.91	5.86	12.34	0.62	0.31	0.62	0.93	3.39	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	539.89	80.86	27.35	2.38	0.00	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	125.41	56.24	25.41	7.18	1.66	1.10	1.10	0.88	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	127.81	54.50	23.91	8.50	2.18	1.70	1.21	0.97	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	131.27	57.40	28.60	8.79	1.41	1.21	0.91	0.81	0.00
hepatoma cell line:Li-7	10484-107A7	912.86	58.94	34.59	0.89	0.44	0.44	0.78	3.56	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	135.07	95.88	11.76	5.63	3.42	2.71	0.80	0.40
hippocampus - adult, donor10196	10169-103B7	416.38	8.52	8.52	11.36	0.00	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	992.13	5.92	17.14	12.04	1.84	1.63	0.41	2.04	1.22
hippocampus, adult, donor10258	10374-105G5	275.37	1.00	8.96	2.49	0.00	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	1406.74	15.16	20.80	4.23	1.76	0.70	0.35	18.33	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	123.29	142.82	53.10	1.22	1.22	1.22	0.61	18.92	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	139.22	148.44	50.86	0.20	0.00	0.20	1.96	11.19	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	158.18	184.84	56.62	0.76	0.76	0.25	3.05	14.98	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	12.97	184.38	58.64	2.26	0.00	0.00	1.69	45.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	14.98	221.55	43.12	0.77	0.77	0.52	2.84	38.22	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	18.60	230.04	39.86	2.66	0.00	0.38	2.28	22.78	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	50.51	174.30	40.58	1.17	2.04	0.88	2.34	34.16	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	64.20	174.28	50.84	3.02	0.65	0.86	1.08	27.36	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	158.07	181.43	55.47	2.50	0.42	0.42	2.50	27.94	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	503.66	153.44	42.62	3.32	0.95	1.42	1.66	15.87	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	377.85	135.81	51.59	2.89	0.48	2.09	2.73	24.91	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	583.75	119.85	47.13	4.71	0.67	0.00	2.02	13.47	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	106.10	79.34	30.20	1.56	0.47	0.47	1.10	9.08	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	120.37	86.47	36.36	3.44	0.49	0.00	3.44	6.88	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	126.55	101.24	33.16	0.87	0.00	0.00	0.87	10.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.21	159.98	27.11	0.76	0.38	0.19	0.76	22.15	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	11.34	146.08	28.34	0.00	0.44	0.00	0.87	22.68	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	13.49	163.42	35.48	1.00	0.00	0.00	1.50	35.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	155.42	203.65	39.56	0.94	0.00	0.57	2.64	33.91	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	171.88	223.72	54.57	1.36	0.45	0.91	0.00	37.74	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	139.70	257.48	52.31	0.63	0.00	0.63	1.57	37.90	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	303.58	142.40	37.40	2.12	0.49	0.65	1.47	24.01	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	338.50	142.54	44.42	0.87	0.58	0.29	0.29	24.97	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	282.48	172.48	47.53	1.79	0.30	1.20	0.60	42.45	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	211.53	114.36	43.97	1.66	0.18	0.00	0.92	14.78	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	208.54	108.41	41.65	1.14	0.29	0.00	2.85	14.55	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	190.27	148.22	49.00	1.22	0.41	0.82	0.41	26.54	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	45.42	153.16	29.93	0.70	0.35	0.35	1.41	13.73	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	42.13	134.30	37.38	0.63	0.00	0.00	1.27	18.05	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	46.00	203.66	39.04	0.91	0.61	0.00	1.51	25.42	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	187.20	169.62	46.02	0.00	1.55	0.00	1.03	26.89	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	168.03	150.77	54.46	0.66	0.00	0.66	1.33	26.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	159.56	193.17	50.28	1.54	1.28	1.80	0.77	20.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	445.08	121.18	44.99	1.79	1.02	1.02	2.05	25.05	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	383.15	138.57	44.68	1.51	0.00	0.00	0.76	22.72	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	497.03	155.26	57.47	2.69	2.35	1.68	1.68	38.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	221.70	120.27	48.06	0.72	0.24	0.24	3.14	14.73	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	230.41	209.01	66.40	1.34	0.00	0.00	2.67	31.20	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	211.71	127.81	53.17	0.49	0.00	0.00	0.49	24.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	18.03	147.61	37.90	1.22	0.31	0.31	2.14	18.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	117.12	22.77	3.25	0.00	3.25	0.00	26.03	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	19.19	164.81	32.43	2.32	0.00	0.33	0.66	39.05	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	184.44	195.39	58.01	1.09	0.55	0.55	0.55	34.48	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	154.16	226.18	56.45	3.62	0.36	0.00	2.90	29.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	126.69	231.67	43.06	1.78	0.71	0.36	1.42	29.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	489.29	100.24	41.77	2.39	0.00	3.58	0.00	33.41	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	538.32	151.41	53.63	3.25	0.81	0.68	2.44	36.02	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	382.81	152.21	50.92	2.42	1.08	0.54	0.54	47.95	0.27
immature langerhans cells, donor1	11904-125F5	299.53	9.20	31.72	3.87	2.42	0.48	0.24	0.48	0.00
immature langerhans cells, donor2	11905-125F6	228.13	8.71	32.48	10.30	3.96	0.79	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	294.59	3.12	7.48	4.73	0.57	1.61	0.28	0.09	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	5539.22	14.96	29.59	0.65	1.63	2.28	1.30	53.97	3.25
kidney, adult, pool1	10017-101C8	2706.74	38.85	23.53	3.00	1.60	0.70	0.50	7.71	1.30
kidney, fetal, pool1	10045-101F9	1517.21	57.51	43.86	8.35	1.84	2.33	2.55	1.41	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	141.74	8.52	17.04	3.12	0.99	0.14	0.28	0.85	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	72.02	33.32	29.72	9.68	1.38	3.46	1.52	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	555.27	3.30	22.75	1.83	3.30	2.75	0.55	1.65	0.18
left atrium, adult, donor1	10079-102A7	1957.10	5.99	8.72	2.72	0.00	2.18	1.09	31.06	1.63
left ventricle, adult, donor1	10078-102A6	3282.71	5.06	5.06	2.02	0.00	1.01	0.00	29.83	1.01
leiomyoblastoma cell line:G-402	10721-110A1	1051.21	98.50	29.82	4.92	1.92	0.82	1.64	1.37	0.27
leiomyoma cell line:10964C	10569-108B2	2270.45	94.48	76.52	7.90	1.80	1.08	3.59	30.18	0.36
leiomyoma cell line:15242A	10570-108B3	2729.36	34.78	61.41	5.98	2.72	1.09	1.63	10.33	0.00
leiomyoma cell line:15425	10571-108B4	2309.91	57.30	58.03	8.26	2.67	2.19	2.91	18.70	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	2857.22	38.10	50.79	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	225.84	23.00	48.10	13.59	1.05	1.05	1.05	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.00	243.55	133.17	19.95	5.19	7.32	7.79	0.83	0.24
liposarcoma cell line:KMLS-1	10782-110G8	441.92	13.12	10.62	0.62	0.16	0.62	0.31	2.19	0.62
liposarcoma cell line:SW 872	10726-110A6	525.25	32.90	22.05	4.63	1.10	1.22	1.46	2.07	0.24
liver, adult, pool1	10018-101C9	440.81	33.06	17.50	0.97	0.65	0.49	0.32	9.89	0.32
liver, fetal, pool1	10086-102B5	650.03	30.10	28.22	4.70	0.00	3.76	0.94	3.76	0.00
locus coeruleus - adult, donor10196	10182-103D2	706.37	6.56	10.94	5.25	1.90	1.46	1.02	2.19	1.02
locus coeruleus, adult, donor10252	10165-103B3	1005.99	7.38	14.95	9.04	1.66	1.85	0.74	2.77	1.48
locus coeruleus, adult, donor10258	10375-105G6	377.50	1.97	7.05	5.64	0.28	0.56	0.56	2.26	0.85
locus coeruleus, newborn, donor10223	10362-105F2	1878.48	34.91	45.85	13.88	2.10	2.10	1.26	44.16	0.00
lung adenocarcinoma cell line:A549	10499-107C4	154.03	54.67	71.69	6.78	4.15	4.71	3.18	0.83	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	348.84	35.16	91.00	26.89	7.58	9.65	3.45	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	657.37	3.56	9.62	1.85	0.13	0.00	0.79	2.64	0.13
lung, adult, pool1	10019-101D1	1626.97	13.35	16.66	4.61	1.30	2.01	0.47	11.34	0.12
lung, fetal, donor1	10068-101I5	1917.37	23.12	32.82	11.70	2.00	1.43	0.29	3.42	1.14
lung, right lower lobe, adult, donor1	10075-102A3	999.83	9.62	19.25	5.04	3.67	0.00	0.46	26.58	0.92
lymph node, adult, donor1	10077-102A5	546.26	21.77	38.82	12.78	1.42	3.31	0.00	9.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	158.25	0.66	6.14	5.70	0.44	0.44	0.44	0.66	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.19	2.72	9.21	17.21	3.17	1.81	0.00	0.00	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	3467.64	26.33	38.23	1.70	0.85	4.25	3.40	11.89	2.55
mature adipocyte, donor1	12231-129F8	778.31	27.97	19.54	5.33	2.22	0.00	1.33	3.11	0.00
mature adipocyte, donor2	12232-129F9	1622.66	43.37	24.07	4.77	3.11	1.25	1.66	10.17	0.42
mature adipocyte, donor3	12233-129G1	691.51	38.64	30.82	5.93	1.19	1.66	1.42	3.56	0.24
mature adipocyte, donor4	12234-129G2	820.71	24.74	17.90	6.32	2.11	1.58	0.79	3.69	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1115.29	53.61	96.97	35.02	7.15	14.53	3.34	5.96	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	545.97	1.13	3.38	4.51	0.00	0.00	0.00	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	829.79	4.78	11.03	5.52	1.47	1.10	0.18	1.29	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	206.18	1.91	5.40	2.54	0.32	0.95	0.32	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	1061.96	17.06	12.79	5.12	0.85	2.13	1.71	9.81	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	494.10	3.88	8.27	4.89	0.84	1.01	0.17	2.36	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	885.61	6.37	11.25	9.34	1.27	1.06	0.00	2.76	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	194.55	0.00	3.85	9.63	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	0.00	0.00	14.35	0.00	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	2328.39	15.79	17.95	6.46	0.00	1.08	0.36	7.18	0.00
medulla oblongata - adult, donor10196	10174-103C3	810.57	28.56	14.28	8.44	0.65	3.89	0.65	7.79	0.00
medulla oblongata, adult, donor10252	10155-103A2	1513.67	17.18	24.15	11.92	1.86	2.17	1.24	5.26	1.70
medulla oblongata, adult, pool1	10038-101F2	825.09	9.06	16.08	8.24	1.22	1.55	0.57	0.73	0.24
medulla oblongata, newborn, donor10223	10361-105F1	2088.64	30.55	31.25	13.54	2.43	2.78	1.74	13.54	0.35
medulloblastoma cell line:D283 Med	10838-111E1	812.14	298.91	26.35	0.66	0.00	0.22	0.66	3.99	0.66
medulloblastoma cell line:ONS-76	10759-110E3	565.14	37.17	35.09	6.24	1.59	0.98	1.35	0.86	0.24
melanoma cell line:COLO 679	10514-107E1	463.44	31.34	20.41	5.03	0.43	1.15	0.72	7.33	0.00
melanoma cell line:G-361	10465-106H6	1311.71	43.71	47.78	11.67	1.36	1.09	0.54	22.80	4.34
meningioma cell line:HKBMM	10691-109F7	660.12	2.71	7.60	0.72	0.36	0.18	0.00	3.08	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	232.63	135.70	30.84	22.91	1.76	5.29	1.76	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	49.51	13.22	9.33	19.44	0.00	2.59	0.00	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	748.91	60.91	28.85	3.22	0.46	1.53	0.92	3.68	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	833.65	38.17	14.00	2.54	0.91	0.55	0.91	3.09	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	725.09	48.45	29.40	7.45	0.41	0.41	1.66	5.38	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	718.53	34.42	22.62	4.50	0.70	0.42	1.83	2.53	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	538.42	38.51	26.38	5.01	0.39	1.54	2.31	1.93	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	845.39	43.03	35.40	4.16	0.00	3.47	1.39	5.55	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	258.48	26.77	37.42	3.78	1.03	1.37	3.09	5.32	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	542.07	41.98	20.24	2.88	0.58	0.35	1.04	5.29	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	661.46	45.23	27.32	4.77	0.40	0.66	1.99	2.79	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	568.79	23.90	22.69	4.19	0.95	0.54	0.95	1.08	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	578.16	20.77	29.16	3.56	0.57	0.57	1.14	2.70	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	343.85	18.44	27.01	3.29	0.33	0.33	0.33	2.96	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	656.16	32.66	23.11	3.87	0.55	0.83	0.69	1.52	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	1389.35	27.58	31.07	5.59	1.05	1.05	1.05	7.33	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	892.81	20.21	27.97	2.86	1.63	1.22	1.43	3.27	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	1136.24	15.46	16.18	2.16	0.36	1.44	1.08	8.27	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	911.50	24.41	31.14	2.69	1.03	1.24	0.83	2.07	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	1016.39	19.61	36.71	1.60	1.14	0.91	2.05	5.02	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1172.24	21.82	32.73	5.87	0.84	2.52	0.00	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	679.79	19.43	15.09	3.29	0.30	0.15	1.34	3.29	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	578.66	37.46	34.05	3.68	1.05	0.61	1.58	2.01	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	1011.70	22.83	24.67	4.42	0.37	0.37	0.00	1.47	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	1420.77	18.31	19.46	1.43	0.86	0.57	0.57	8.87	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	1332.51	12.63	19.37	4.21	1.68	0.84	0.42	4.63	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	1993.37	30.14	16.44	3.65	0.00	0.91	0.46	17.81	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	2213.05	37.60	17.65	1.53	1.02	0.51	0.00	15.86	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	2435.38	32.98	21.20	2.36	0.52	1.05	0.52	14.13	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	2530.62	32.97	16.64	3.08	0.92	0.62	0.00	15.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	2395.91	36.48	21.65	2.12	1.18	0.94	1.41	17.42	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	2472.76	35.54	21.66	0.68	0.34	1.02	0.68	12.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	2487.91	40.08	13.75	2.75	1.18	0.79	0.39	14.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	2358.63	41.24	13.90	2.32	0.93	1.85	0.93	18.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	3912.59	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	2592.87	39.51	24.80	2.02	1.44	1.73	1.15	12.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	2437.59	35.03	17.40	2.01	1.78	0.89	0.89	8.48	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	2521.29	26.20	18.03	2.16	1.92	1.20	0.48	11.06	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	2320.98	36.67	22.73	3.67	0.73	2.20	0.00	7.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	2452.65	34.24	21.82	3.36	2.01	2.01	1.01	14.10	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	2434.98	42.98	22.52	2.87	0.82	1.64	0.41	14.74	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	2523.65	36.51	17.61	1.29	0.00	0.86	0.86	14.18	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2562.14	27.34	16.41	5.47	0.00	0.00	2.73	8.20	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	2484.36	10.33	15.49	0.00	0.00	0.00	0.00	20.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	2141.31	29.23	16.56	1.62	1.30	0.32	0.32	14.94	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2031.16	16.00	14.55	2.91	0.00	0.00	0.00	11.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	2443.64	29.85	18.66	3.73	1.07	0.00	0.00	26.12	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	2137.65	25.35	11.45	1.64	0.00	0.00	0.82	10.63	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	2196.27	25.66	11.66	1.17	0.00	0.39	0.39	12.05	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2251.93	25.18	16.79	0.00	0.00	0.00	0.00	12.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2231.33	29.80	9.93	0.00	0.99	0.00	0.00	17.88	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	2145.25	4.77	0.00	0.00	0.00	0.00	0.00	33.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	2052.25	25.50	13.64	1.78	0.00	2.37	0.00	17.79	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	2277.30	25.59	7.31	6.09	0.00	1.22	0.00	9.75	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	2380.62	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	2391.02	23.44	17.73	2.53	0.63	1.90	0.63	13.93	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	2016.31	24.49	13.80	1.38	0.69	1.03	0.34	11.73	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2028.85	32.24	21.49	2.15	0.00	0.00	0.00	19.34	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	2327.22	39.92	7.98	7.98	0.00	0.00	0.00	7.98	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	1370.67	41.33	20.66	0.00	0.00	0.00	0.00	13.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	1406.18	40.75	15.48	2.44	0.00	0.81	0.41	6.93	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	1351.35	27.81	13.51	0.00	0.00	2.38	0.79	7.94	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	1190.84	31.24	8.25	1.77	0.59	0.00	0.00	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1197.26	32.11	8.42	2.81	0.62	0.94	0.00	4.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1231.08	21.39	12.03	1.34	0.00	1.34	1.34	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1122.36	48.49	22.47	3.55	1.18	0.00	1.18	11.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	963.00	56.50	10.27	7.70	2.57	0.00	2.57	10.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	1037.41	55.76	15.83	4.13	0.69	2.07	0.00	8.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	847.61	46.51	22.76	1.98	1.48	0.99	0.00	2.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	769.35	32.52	11.22	2.24	0.00	2.24	0.00	6.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	831.97	41.34	17.17	1.27	0.00	0.64	0.64	8.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1574.86	41.91	25.39	2.82	1.21	0.00	1.61	11.69	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	1685.59	41.43	39.25	0.00	0.00	0.00	0.00	8.72	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1706.73	34.21	30.41	1.27	2.53	1.27	2.53	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	528.60	23.06	26.10	0.61	0.00	2.43	2.43	10.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	686.88	40.67	22.59	4.52	0.00	0.00	0.00	22.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	594.70	19.77	29.65	2.47	0.82	0.82	1.65	4.94	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	641.11	35.32	12.90	1.59	0.40	0.99	0.40	4.37	4.17
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	705.77	43.81	10.38	0.65	0.00	0.00	0.97	5.84	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	718.13	47.88	11.20	2.04	0.00	0.00	0.00	5.09	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	1136.59	8.51	17.02	1.55	0.00	0.77	0.00	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	1005.21	17.48	86.23	15.12	11.10	9.45	0.94	2.83	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	243.49	202.25	82.24	3.24	0.93	0.23	4.87	1.39	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	1465.84	115.39	85.47	0.00	4.27	4.27	0.00	17.09	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	1066.55	204.37	118.68	4.11	2.57	1.64	6.17	6.99	0.51
mesothelioma cell line:Mero-25	10850-111F4	212.88	47.21	62.19	1.82	0.68	0.91	1.82	0.91	0.00
mesothelioma cell line:Mero-41	10851-111F5	2535.45	71.88	52.56	3.91	0.98	0.98	2.93	5.38	1.22
mesothelioma cell line:Mero-48a	10852-111F6	2041.59	27.46	59.34	9.08	1.11	1.55	2.66	6.64	0.00
mesothelioma cell line:Mero-82	10853-111F7	606.03	61.76	52.04	1.31	0.79	0.79	1.31	3.94	0.79
mesothelioma cell line:Mero-83	10854-111F8	432.36	64.17	53.79	0.68	0.85	0.17	2.38	7.15	0.00
mesothelioma cell line:Mero-84	10855-111F9	1861.17	64.71	57.89	2.53	1.77	0.25	1.26	3.29	0.76
mesothelioma cell line:Mero-95	10856-111G1	2366.08	132.71	92.55	3.93	0.41	1.45	5.59	16.98	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	969.04	27.00	33.13	5.63	2.15	0.83	0.83	3.15	0.50
mesothelioma cell line:NCI-H226	10846-111E9	1769.56	108.23	64.98	2.17	0.90	1.45	3.08	7.06	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	1241.54	172.53	61.33	3.25	1.37	0.34	2.05	5.12	0.51
mesothelioma cell line:NCI-H28	10845-111E8	35.12	31.81	26.72	10.18	1.53	1.53	1.27	0.25	0.00
mesothelioma cell line:No36	10857-111G2	76.66	53.82	49.26	17.61	3.91	2.28	0.65	0.65	0.33
mesothelioma cell line:ONE58	10858-111G3	1396.22	54.19	49.86	3.52	0.81	0.54	0.81	5.15	1.08
migratory langerhans cells, donor1	11901-125F2	1357.85	0.77	7.68	3.45	0.77	0.19	0.00	3.65	0.38
migratory langerhans cells, donor2	11902-125F3	724.39	0.73	2.81	2.81	0.24	0.24	0.00	2.44	0.12
migratory langerhans cells, donor3	11903-125F4	339.76	1.08	12.20	3.05	0.54	0.54	0.00	1.26	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	632.72	7.18	44.73	3.59	1.63	1.96	0.98	2.61	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	701.30	16.32	26.92	1.91	1.06	1.70	3.39	4.66	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	89.15	12.67	59.66	6.22	4.15	3.23	2.53	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	648.71	22.26	43.39	18.65	5.33	4.19	0.19	3.81	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1107.28	61.35	48.79	9.24	5.17	4.07	0.92	2.96	0.55
myeloma cell line:PCM6	10474-106I6	1.58	16.41	147.06	45.46	19.77	11.86	2.17	0.20	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	457.58	55.80	121.75	1.52	3.04	2.54	4.57	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	702.38	48.64	67.28	11.57	3.33	0.98	1.77	2.75	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	2275.07	9.03	34.32	1.56	3.12	1.89	1.00	4.57	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	2519.42	9.27	36.11	2.57	2.06	2.43	1.18	4.34	0.66
nasal epithelial cells, donor2	12227-129F4	3350.02	12.14	21.53	1.66	0.00	1.66	1.66	4.42	1.10
neuroblastoma cell line:CHP-134	10508-107D4	9.66	3.45	1.38	1.84	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	455.18	42.47	29.00	20.02	1.31	2.99	1.12	1.31	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	26.99	65.80	68.54	2.95	1.05	0.21	2.95	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	138.83	45.28	16.59	8.57	0.75	0.37	0.75	0.93	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	112.92	118.61	74.73	6.41	2.37	2.14	2.14	1.42	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	519.81	82.99	59.08	4.59	0.79	1.58	1.90	13.62	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	166.64	211.73	85.33	7.25	1.61	2.01	4.03	1.01	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	98.54	61.67	66.76	7.63	1.27	1.91	1.27	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	1765.22	14.91	13.84	1.33	0.27	0.53	0.80	2.66	2.40
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1198.05	3.38	17.42	12.85	0.68	0.85	0.34	1.52	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	745.27	12.01	10.41	20.81	1.60	2.40	0.00	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	700.84	37.83	32.70	1.60	0.64	0.96	1.60	7.05	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	2143.37	23.91	10.51	1.58	0.00	0.26	0.00	7.09	1.05
nucleus accumbens, adult, pool1	10037-101F1	315.71	3.94	7.31	4.78	0.84	1.03	0.09	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	434.74	0.00	2.06	6.18	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	1037.22	5.90	12.88	9.93	1.07	1.34	0.27	2.68	1.07
occipital cortex, newborn, donor10223	10355-105E4	2467.17	15.65	18.20	4.00	1.46	0.73	1.09	5.46	1.09
occipital lobe, adult, donor1	10076-102A4	208.87	2.36	4.46	2.10	0.79	0.79	0.00	3.41	0.26
occipital lobe, fetal, donor1	10073-102A1	90.11	1.72	2.15	5.58	0.43	0.43	0.00	0.43	1.29
occipital pole, adult, pool1	10036-101E9	248.51	2.29	5.12	4.97	0.08	0.39	0.00	0.39	0.16
olfactory region, adult	10195-103E6	465.21	3.25	5.35	5.92	0.57	0.38	0.19	1.15	0.57
optic nerve, donor1	10277-104E7	176.09	4.00	2.00	6.00	0.00	4.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	0.00	0.00	0.00	0.14	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	3068.99	18.46	22.01	2.03	1.02	1.52	0.34	14.73	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	873.48	99.80	93.10	4.16	3.23	1.50	3.47	4.04	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	2369.08	4.41	11.46	1.47	0.59	0.00	0.00	13.52	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	152.30	77.55	42.98	5.61	0.00	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	1993.78	178.98	92.03	9.12	3.18	3.82	4.67	11.66	0.21
ovary, adult, pool1	10020-101D2	1874.30	28.39	24.63	7.08	1.48	1.92	0.26	14.94	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	554.91	14.30	28.96	4.40	0.55	0.55	0.73	2.02	0.37
pancreas, adult, donor1	10049-101G4	836.23	16.93	18.81	2.82	0.94	4.70	0.00	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	182.28	59.79	51.28	4.94	2.21	1.70	0.68	0.85	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	408.33	21.36	46.53	16.39	3.31	3.31	1.32	3.15	0.17
paracentral gyrus, adult, pool1	10035-101E8	248.85	3.20	6.13	6.22	0.46	0.55	0.18	0.37	0.09
parietal cortex, adult, donor10258	10373-105G4	236.35	5.87	4.40	5.14	0.00	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	434.50	2.82	6.58	5.64	2.82	0.94	0.00	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	914.97	6.27	6.84	7.13	1.43	0.57	0.86	3.14	0.29
parietal lobe, adult, pool1	10034-101E7	305.69	3.70	5.38	6.96	0.53	0.62	0.09	0.35	0.09
parietal lobe, fetal, donor1	10072-101I9	163.90	0.97	7.76	4.85	0.97	1.94	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	2849.56	13.83	19.44	5.23	1.50	1.87	0.75	5.23	2.62
parotid gland, adult	10199-103F1	751.71	9.25	9.87	1.23	3.08	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	3758.71	16.11	9.67	4.30	1.07	0.54	0.00	27.39	4.83
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	314.60	60.06	67.87	10.23	2.79	3.72	1.86	1.86	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	1210.58	27.24	38.61	2.91	0.58	0.58	2.04	4.52	0.58
pineal gland - adult, donor10196	10179-103C8	579.23	12.26	14.84	15.48	0.00	0.65	0.65	2.58	0.00
pineal gland, adult, donor10252	10160-103A7	1181.46	14.81	18.95	17.77	2.37	0.59	0.00	1.78	4.15
pineal gland, adult, donor10258	10377-105G8	696.68	19.44	10.66	10.03	0.00	0.63	0.00	4.39	0.00
pituitary gland - adult, donor10196	10180-103C9	231.70	5.06	7.08	18.21	0.00	2.02	1.01	4.05	0.00
pituitary gland, adult, donor10252	10162-103A9	312.71	4.17	15.64	17.72	1.56	2.61	0.52	3.13	0.00
pituitary gland, adult, donor10258	10378-105G9	129.39	5.11	7.66	17.88	0.00	2.55	0.00	6.81	0.85
placenta, adult, pool1	10021-101D3	3099.30	10.64	27.84	3.98	2.15	2.15	0.97	8.49	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	548.64	5.83	27.02	21.32	3.31	2.38	0.00	1.19	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	861.77	63.81	34.55	5.76	0.93	0.93	0.93	2.33	0.78
pons, adult, pool1	10033-101E6	401.93	4.13	7.32	7.14	1.20	1.38	0.00	0.34	0.00
postcentral gyrus, adult, pool1	10032-101E5	234.68	2.70	5.40	5.49	0.26	0.87	0.35	0.26	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	8.37	56.47	33.46	4.18	6.27	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	280.91	137.70	22.03	5.51	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	657.20	129.09	23.47	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	514.62	20.25	58.41	15.15	3.64	2.62	2.18	1.02	0.87
prostate cancer cell line:PC-3	10439-106E7	509.11	102.55	102.91	13.25	3.27	3.45	2.72	1.45	0.54
prostate, adult, pool1	10022-101D4	3198.24	15.60	20.77	7.07	1.81	2.81	0.27	12.52	1.00
putamen, adult, donor10196	10176-103C5	497.86	5.19	5.67	8.03	1.42	1.42	0.24	0.71	0.71
putamen, adult, donor10252	10152-102I8	709.78	1.96	7.84	5.88	0.00	1.96	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	298.34	18.58	15.30	5.46	1.09	1.09	0.00	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	225.67	2.90	6.04	4.11	0.24	0.97	0.00	0.97	0.00
putamen, newborn, donor10223	10365-105F5	2003.84	14.99	24.74	6.00	1.50	0.75	0.75	15.74	0.75
rectal cancer cell line:TT1TKB	10469-106I1	27.06	1.75	7.27	2.33	2.62	0.87	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	1425.77	13.91	8.35	5.56	0.00	1.39	0.00	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	2264.14	123.38	47.06	1.48	1.06	0.85	1.27	5.72	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	926.59	38.52	24.02	7.87	0.83	1.24	0.00	0.83	3.31
retina, adult, pool1	10030-101E3	1184.25	52.98	29.42	4.67	1.09	1.29	1.19	2.29	0.70
retinoblastoma cell line:Y79	10475-106I7	213.04	309.16	26.50	1.82	0.26	0.52	1.30	1.56	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	516.63	62.09	53.11	7.13	1.84	2.46	1.72	1.97	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	442.05	255.89	57.65	5.34	0.28	0.56	1.69	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	1135.27	64.42	30.31	3.03	0.76	1.52	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	3178.54	37.07	24.93	3.72	2.10	2.10	0.16	22.01	0.81
salivary acinar cells, donor2	11772-123I8	10953.85	75.45	31.81	3.30	3.17	3.03	1.79	110.56	1.24
salivary acinar cells, donor3	11773-123I9	12152.62	39.06	28.47	2.65	3.97	3.31	0.00	14.57	1.32
salivary gland, adult, pool1	10093-102C3	955.16	12.01	8.58	4.00	0.57	1.14	1.14	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	11.55	1.01	3.71	7.59	0.76	1.43	0.00	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	8.82	1.18	6.47	7.99	0.59	0.71	0.00	0.00	0.00
seminal vesicle, adult	10201-103F3	3339.50	30.69	31.22	10.05	4.76	1.59	3.17	19.58	6.35
serous adenocarcinoma cell line:JHOS-2	10639-108I9	479.29	9.96	24.29	2.92	2.43	2.19	0.97	1.70	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	447.65	7.05	17.61	3.77	0.75	0.25	0.25	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	713.51	30.11	36.13	8.03	0.00	3.01	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	934.60	28.88	25.79	1.34	0.81	0.40	0.40	2.01	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	141.59	21.11	53.94	13.48	3.21	5.42	1.44	0.66	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	6.97	0.90	6.45	2.45	0.52	0.26	0.13	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	13527.02	4.97	0.71	1.42	0.00	0.71	0.71	58.17	2.13
skeletal muscle, adult, pool1	10023-101D5	9479.72	15.11	5.28	2.64	1.08	1.08	0.72	72.68	1.32
skeletal muscle, fetal, donor1	10066-101I3	6710.49	35.18	15.08	9.05	0.00	1.01	0.00	38.19	4.02
skin, adult, donor1	10074-102A2	2795.51	13.57	47.50	0.00	6.79	6.79	0.00	54.28	0.00
skin, fetal, donor1	10065-101I2	2309.66	23.99	18.94	6.31	0.63	1.26	1.26	30.93	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	167.10	9.67	14.68	6.67	1.00	0.33	0.33	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1647.58	35.62	28.05	16.39	0.63	3.15	1.89	8.83	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	278.71	33.73	190.43	43.95	18.70	14.84	5.40	1.73	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	23.90	12.03	25.71	16.98	0.66	3.79	0.99	0.49	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	67.88	203.64	51.79	35.87	0.48	3.86	1.29	0.64	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	100.24	3.27	3.27	2.62	0.65	0.00	0.00	0.65	0.00
small intestine, adult, pool1	10024-101D6	959.60	7.17	11.82	5.26	1.31	1.31	0.12	9.08	0.24
small intestine, fetal, donor1	10064-101I1	686.48	11.30	9.58	8.60	1.47	1.97	0.25	5.90	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	861.67	133.35	202.60	20.52	8.21	11.80	5.64	7.69	0.51
smooth muscle, adult, pool1	10048-101G3	3813.50	9.82	8.79	2.33	0.78	0.78	0.00	8.53	1.55
somatostatinoma cell line:QGP-1	10781-110G7	28.68	0.80	0.80	0.27	0.00	0.27	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	472.58	4.59	11.47	9.41	2.52	1.38	0.23	2.75	1.38
spinal cord, adult, donor10252	10159-103A6	1186.76	10.65	27.20	15.77	2.37	1.18	0.00	3.55	2.37
spinal cord, adult, donor10258	10369-105F9	598.40	4.15	15.22	12.45	0.69	1.38	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	444.57	9.76	10.98	9.15	1.22	0.61	0.00	4.27	0.00
spinal cord, newborn, donor10223	10359-105E8	1668.78	11.94	25.26	5.97	3.67	2.76	0.46	4.13	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	1576.59	7.02	12.55	1.64	0.45	0.75	0.60	2.69	0.30
spleen, adult, pool1	10025-101D7	477.43	16.19	38.11	13.22	4.96	1.98	0.55	2.53	0.11
spleen, fetal, pool1	10044-101F8	1399.28	14.86	41.87	11.60	4.45	4.21	1.27	2.22	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	713.82	16.87	67.08	23.60	8.38	4.87	0.62	0.83	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	2683.52	2.09	7.78	0.57	0.19	0.19	0.19	4.56	3.42
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	3029.75	6.64	22.02	5.24	1.75	2.10	0.70	5.94	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	115.72	7.43	20.72	1.95	1.17	1.56	0.78	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	0.11	0.23	3.26	1.91	0.34	0.45	0.00	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	492.65	41.09	58.88	13.98	3.39	7.20	0.00	2.12	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	528.42	30.04	48.65	12.27	3.81	3.38	0.85	1.69	0.00
stomach, fetal, donor1	10062-101H8	1390.50	13.88	17.09	5.34	1.07	0.00	0.00	2.14	1.07
submaxillary gland, adult	10202-103F4	876.74	3.99	13.10	2.85	0.00	0.57	0.00	6.27	0.57
substantia nigra - adult, donor10196	10178-103C7	759.84	54.27	108.55	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	999.27	6.44	15.79	6.85	1.25	1.25	0.83	3.95	1.66
substantia nigra, adult, donor10258	10371-105G2	397.25	2.07	9.83	4.14	1.55	0.00	0.52	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	2154.35	21.90	21.90	12.01	0.00	2.12	0.00	21.20	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	65.11	32.56	71.99	29.58	6.42	6.19	3.90	0.92	1.15
temporal lobe, adult, pool1	10031-101E4	294.32	5.26	6.19	6.61	0.08	0.93	0.34	0.17	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	91.17	2.85	2.14	4.27	0.71	1.42	0.00	2.14	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	155.16	3.52	7.91	3.96	0.44	2.64	0.88	1.32	0.00
tenocyte, donor1	11763-123H8	1240.01	40.15	26.18	4.89	0.00	0.70	1.05	3.84	0.35
tenocyte, donor2	11765-123I1	1023.96	26.71	16.79	1.91	1.14	0.76	1.14	3.43	0.00
tenocyte, donor3	11768-123I4	1661.69	32.99	28.91	5.19	1.48	1.11	1.48	5.56	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	435.27	46.40	28.38	1.02	0.00	0.51	0.68	2.04	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	288.10	71.52	32.68	0.46	0.15	0.15	0.77	2.93	0.15
teratocarcinoma cell line:PA-1	10807-111A6	166.45	100.27	59.20	0.62	0.93	0.31	1.70	1.70	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	506.27	42.27	28.56	0.51	0.13	0.13	1.02	11.30	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	2129.49	72.23	84.71	1.13	0.38	0.76	1.89	8.32	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	739.55	52.35	49.19	0.87	0.44	0.11	1.09	8.18	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	400.61	10.75	7.17	0.33	0.00	0.00	0.65	1.30	0.00
testis, adult, pool1	10026-101D8	1072.76	22.76	22.33	13.85	5.48	3.54	1.18	24.59	0.75
testis, adult, pool2	10096-102C6	401.01	20.30	32.93	18.04	4.96	2.71	0.90	1.35	0.00
thalamus - adult, donor10196	10168-103B6	589.53	2.21	8.83	5.52	2.21	1.10	1.10	3.31	0.00
thalamus, adult, donor10252	10154-103A1	966.30	6.72	16.10	9.06	1.56	2.50	0.31	2.81	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	926.85	4.62	23.09	9.24	0.00	1.54	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	328.06	2.80	5.93	3.79	0.00	0.33	0.16	1.98	0.82
thalamus, newborn, donor10223	10366-105F6	1632.76	11.51	18.41	5.18	0.58	0.00	0.00	18.41	0.00
throat, adult	10209-103G2	5975.60	21.72	18.48	5.99	2.50	1.50	0.00	48.94	3.75
throat, fetal, donor1	10061-101H7	1855.66	21.94	22.24	5.79	2.13	1.22	0.61	10.06	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	29.21	116.26	70.35	41.14	3.78	2.98	0.99	0.79	0.00
thymus, adult, pool1	10027-101D9	535.05	105.38	240.88	111.25	47.52	46.82	2.49	12.73	1.59
thymus, fetal, pool1	10043-101F7	2190.62	76.16	220.17	66.91	32.21	25.98	3.84	10.08	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	1077.65	46.80	39.76	5.05	1.73	1.20	0.93	7.45	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	552.62	125.30	71.80	2.10	1.12	0.56	3.49	3.35	0.56
thyroid, adult, pool1	10028-101E1	2584.12	12.04	18.38	5.88	2.15	2.43	0.84	12.88	2.43
thyroid, fetal, donor1	10060-101H6	1001.66	10.02	13.97	3.69	1.58	1.58	1.05	3.95	1.58
tongue epidermis (fungiform papillae), donor1	10288-104F9	1496.69	9.24	0.00	6.16	0.00	3.08	0.00	15.40	3.08
tongue, adult	10203-103F5	5700.70	33.03	12.09	3.95	2.56	2.79	0.47	42.56	2.09
tongue, fetal, donor1	10059-101H5	6636.13	39.80	18.52	3.94	1.97	4.34	1.18	52.02	2.76
tonsil, adult, pool1	10047-101G2	4831.37	21.44	40.47	18.33	5.51	3.21	1.10	4.81	1.30
trachea, adult, pool1	10029-101E2	2203.90	20.53	19.30	5.15	1.64	1.15	0.25	8.59	0.82
trachea, fetal, donor1	10058-101H4	1526.85	17.70	15.00	4.23	1.15	0.00	1.15	9.62	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	1782.36	49.95	27.63	4.61	0.35	0.71	2.83	5.67	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	348.73	98.88	94.73	11.65	5.17	5.37	2.33	0.81	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	298.02	156.22	104.04	15.04	5.33	6.58	3.13	13.95	0.47
tridermal teratoma cell line:HGRT	10694-109G1	460.41	106.54	79.91	5.71	0.00	5.71	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	196.47	31.91	34.62	5.50	2.20	1.78	1.44	1.95	0.25
umbilical cord, fetal, donor1	10057-101H3	2564.31	6.26	2.09	4.17	2.09	2.09	2.09	12.52	2.09
uterus, adult, pool1	10100-102D1	4478.99	17.23	15.87	4.78	2.05	0.85	0.34	8.19	4.10
uterus, fetal, donor1	10055-101H1	3360.30	19.45	14.85	2.56	1.02	0.51	0.51	12.29	2.05
vagina, adult	10204-103F6	15577.27	31.66	51.70	10.99	5.17	7.11	2.58	75.61	14.22
vein, adult	10191-103E2	2017.94	34.63	60.50	21.26	7.89	7.67	0.66	17.97	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	294.54	4.81	27.77	14.15	1.87	0.80	0.27	0.27	0.00